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INTRODUCTION 
Cancer is the one of the leading cause of death; worldwide accounting for 
7.6 million deaths that are around 13% of all deaths in 2008, and about 70% of 
all Cancer deaths occurred in low and middle income countries. Death due to 
cancer are projected to continue to rise above 11million by 2030.(1)        
In 1980, A Meta Analysis of 58 studies showed that younger patients (2) 
reported significantly more depression, anxiety and general distress than studies 
with older patients.  
A study done by Derogatis et al(3)  noted that prevalence of psychiatric co-
morbidity is 47% of the cancer  patients comparatively  high than the general 
medical patients. More than two thirds of those represent adjustment disorders, 
10 to 15 percent major depression, Adjustment disorder is the most common 
psychiatric co-morbidity seen cancer patients.    In-patient studies show higher the 
incidence of 20% to 45% of depression and 15% to 75% of delirium.  
Conceptually, these are disorders with emotional and behavioural symptoms 
which are responses to an identifiable stressor.   
Literally the term “Cancer” refers to a set of conditions that have the 
growth of cells that invade tissues and organs of the human body in common (2). 
It is a multisystem illness. The presenting signs and symptoms may be due to 
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primary tumour itself, metastasis, and para-neoplastic syndrome or due to drug 
treatment.  
The causes of Cancer are varied, but psychological and behavioural factors 
such as chronic stress, depression and social isolation may contribute to the 
initiation and progression of certain cancers  by Reiche et.al (4,5).  
The awareness about the cancer diagnosis and its relationship to 
psychiatric morbidity has been a subject of debate. The experience of having 
“Cancer” has been associated with high levels of psychological stress.  Galan 
noted a relationship between dysphoric affect and cancer long ago.  Correlation 
between Neoplasia and psychological disorder are noted by numerous 18th and 
19th century physicians (6).   The non awareness on the part of the patients can be 
attributed to many causes notably illiteracy, denial, decision of family member, 
and their society.  It may also be due to the stigma attached to the word cancer, 
fear of social and financial implication (7). 
Despite of biomedical advance, Cancer is still considered as equal and 
synonymous with death, pain and suffering (8). The diagnosis of Cancer causes a 
number of emotional reactions. These patients develop fear of pain, surgery, 
dependency, financial burden and fear of death which often result in depression 
and anxiety. The distress in a patient with cancer may be due to multiple factors. 
The un-remitting physical symptoms like pain, fatigue, nausea, sleep 
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disturbances may increase the distress. Patients who are being investigated to rule 
out Cancers also develop distress and anxiety about their outcome (9).  
Recent studies found that the factors such as socio-economic status, social 
support, performance capacity, recent losses, and awareness of the diagnosis of 
Cancer might affect the rate of psychiatric disorders (9-11). 
 It is thought that socio-cultural context plays an important role in the 
occurrence of mental disorders. As Bailey et.al (12) suggested culture may 
influence symptom expression. In Asia, the individuals suffering from depression 
tend to presented with somatic symptoms.  While neglecting the psychological 
symptoms. Some Asian patients believe that cancer is a form of God’s 
punishment for their past mistakes (13); therefore, patients and their families are 
reluctant to discuss their emotional distress and experiences due to cancer. In 
general, cultural beliefs can also influence, the way the health care system 
practices, medicine, as well as the mental health help-seeking behaviours of 
cancer patients with depression (14). 
Various mental disorders are risk factors for the development of some 
cancers. Mental disorders may appear as co-morbidities with the clinical 
condition, which may negatively impact disease diagnosis and treatment and 
emotional and financial costs. 
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Psychiatric co-morbidity in the medically ill patients is a reality but is 
often under-diagnosed and untreated as there is a tendency to explain away the 
symptom experienced by the patients.   
Attention to the psychosocial aspects of the disease is equally important to 
cancer treatment; especially regarding psychopathologies because they 
significantly impact morbidity, low adherence to treatment, hospitalization 
duration, prognosis, quality of life, and patient survival (15-18). 
Scope of the study: 
• By identifying the underlying psychiatric disorders in cancer 
patients.  we will create awareness among the treating physicians to 
look for psychiatric morbidities. 
• Early Identification and referral leads to prevention of potential risk 
like suicide. 
• Identification of the factors associated with psychiatric disorders in 
cancer patients may contribute to the development of possible 
preventive measures. 
• To plan interventions efficiently, it is important to gain insight into 
the prevalence, severity, course of the psychological sequelae, and 
the variables influencing them.  
• It is in this context, that the study was planned to find the prevalence 
of psychiatric illnesses in cancer patients. 
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REVIEW OF LITERATURE 
Historical Background 
The history of cancer is the history of life itself.  It’s probably existed 
since the civilization began.  Cancer has intense propensity to replicate and 
grow more rapidly than normal cells.  Hippocrates in 400 BC coined the word 
“Karkinos” in Greek which means swelling or “onkos” (load mass) on one of 
the islands of Greece. The environment factors in the causation of cancer was 
addressed by Surgeon Sir Percivall Pott with high incidence of scrotal cancer in 
chimney sweeper due to the effect of soot, which is a chemical carcinogen.  
The basic understandings of the normal and abnormal cells were studied 
by German pathologist Rudolf Virchow in 1855. The general consideration that 
the cancer is a genetic disease.  Where, there is an alteration in the genome of 
the somatic cells, there is a progression of cancer.  With these basis the field of 
oncology has improved to multiple levels.  
Physicians were reluctant to discuss a diagnosis of cancer with patients 
and their families, as cancer represented inevitable death due to lack of effective 
treatments, to reveal a diagnosis of cancer was regarded as cruel and 
destructive. With the advent of Anaesthesia and Antisepsis, curative surgical 
resection of early stage tumours became possible. 
The American Cancer Society was formed in 1913, to educate the public 
about the warning signs of cancer and to fight fatalism that interfered with early 
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presentation for treatment. In 1937 the National Cancer Institute was established 
to seek aetiology and treatments for cancer. In the 1950s the addition of 
chemotherapy to the combined treatment modalities resulted in cure of several 
childhood tumours. By the early 1970s, with improvements in survival, 
oncologist’s became more comfortable in discussing cancer diagnoses with their 
patients, and the patients reluctance to identify themselves as cancer patients 
diminished.  
Hospice programs were developed to improve pain management and 
palliative care.  This program meant with increased interest in delivering the 
best supportive care to patients at the end of life. Clinician’s enhanced comfort 
with communicating a diagnosis of cancer, increased concern for palliative 
symptom control, and the growing interest in quality of life and patient rights 
emphasized the need for supportive and psychological aspects of care.  
In the 1980s psycho-oncology units began to develop in larger cancer 
centres. Prevalence studies of psychiatric and psychological sequelae in cancer 
were reported. Special units were developed throughout Europe and the United 
States during the 1970s.  This is followed by societies such as the British 
Psychosocial Oncology Group (1983), the International Psycho-Oncology 
Society (1984), and the Japanese Psycho-Oncology Society (1985). 
Conferences, journals (Journal of Psychosocial Oncology, 1982; Psycho-
Oncology, 1992), textbooks, and training programs followed thereafter. 
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In the 1990s, behavioural research in changing habits (e.g., smoking, diet, 
and lifestyle) improved education of the public on cancer prevention. Health-
related quality-of-life assessments and more recently patient-reported outcomes 
have become part of outcome measures in clinical trials. 
In the early 21st century, psycho-oncology, a relatively young discipline, 
continues to grow, with the development of novel psychotherapy modalities for 
advanced cancer patients, intervention trials to improve symptom control in the 
terminally ill, increased awareness of the role of communication skills training, 
researcher’s efforts to understand and conceptualize the effects of chemotherapy 
on the central nervous system (CNS), and recognition of the special needs of 
elderly cancer patients with the rapidly growing elderly population worldwide. 
It is important to emphasize that despite all the developments out-lined, 
historical attitudes toward cancer have contributed to the reluctance of patients 
and families to identify their emotional problems to the clinicians, even today, 
especially in underserved populations, different cultures, and several parts of the 
world.(Kaplan and Sadock,2009)(19)  .   
The advance in oncology has improved to multiple levels. In the recent 
years.  
• There is redesigning of the genomic maps from a histological to a 
molecular level.   
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• Drugs that alter the molecular basis of cancer, shows improvement 
in treatment of cancers, which reveals that the somatic genetic 
alterations are the legitimate target of therapy.  
• Alteration in the DNA which is tumour specific represents a highly 
sensitive biological marker for disease detection and to monitor the 
disease progress.  
• Genotyping helps the oncologist to treat easily based upon the 
aetiology.   
PSYCHO-ONCOLOGY IN INDIA 
The role of psychosocial factor in cancer has been recognised as 
important since a long time by Indian clinicians.  Active research and activities 
have been pursued over the last decade (20).  One of the factors for this has been 
the relatively low number of mental health professionals.  In the country having 
to manage an extremely large number of people with mental illness; hence few 
could spare time for the care of those with severe physical disease as cancer. 
Oncologist’s are focus on the therapeutic or curative aspect of the large 
number of cancer patients.  The system of “consultation-liaison psychiatry” is 
not well developed, such facilities being available in a few hospitals in India.  
The emphasis on psychiatry during the Undergraduate and Postgraduate 
Medical Training is limited.  Psychological reaction to cancer are considered a 
natural phenomenon and less important than the physical care.  Cancer patients 
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seek treatment when their disease is fairly advanced; care of physical condition 
is the major focus. 
The occupation therapy centre at TATA Memorial Hospital Mumbai has 
proved to be an effective and well developed centre for the rehabilitation of 
cancer patients.  The Indian cancer society provide the support and care for the 
cancer patients, Shanti Avedna Asham at Mumbai , Sevagram in Kerala provide 
palliative care and support to cancer patients.  First palliative care out-patient 
clinic was opened at Calicut.  
Studies have been conducted on emotional reaction of cancer patients, 
their personality, effects of radiation therapy other treatments, and 
communication patterns.  Psychiatric aspects of patients with cancer pain and 
palliative care have also been studied.  Head and Neck cancers, like Laryngeal 
cancers, and Haematological malignancies, like Leukaemia, have received 
relatively more attention by researches. Studies have also been carried out on 
quality of life aspects and subjective well being of cancer patients, especially 
those receiving radiotherapy. 
These studies indicate that the reaction to cancer is quite similar to the 
Western population, with some cultural differences.  Lack of awareness about 
the disease and treatment is quite widespread, because due to inadequate 
information provided to the patients as well as due to denial on the part of the 
patients. 
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Mixed anxiety depressive disorder is the commonest diagnosis in cancer 
patients.  Fatalism and resort to religion were noted to be the commonest coping 
mechanism in Head and Neck cancer patients, as another study noted.   
Subjective well being and quality of life was found to be satisfactory in 
patients receiving radiation therapy.  A survey done among the Indian 
population in quality of life, documented that Indian patients more importance 
to spiritual issues, and have satisfaction.  Families have been found to be very 
supportive.  
FACTORS IN ADAPTATION TO CANCER 
The cancer patient derived factors that modulate, adaptation to cancer 
originate from three sources: from three variables. (21)  
Factors Determine the Adaption and Adjustment to Cancer. 
1. Society derived Open discussion versus unrevealed secrets 
Knowledge of treatment options, prognosis and 
participation as partner in treatment  popular 
belief  
Example:  stress causes cancer 
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2.Patients derived 1. Intrapersonal development stage at times 
of cancer, coping ability emotional 
maturity at the time of cancer, spiritual 
or religious belief that influence coping. 
2. Interpersonal : spouse, family, friends,  
3. Socioeconomic status is the thirds set of 
patient derived factor. 
3.Cancer derived Site, stage symptom and prognosis, treatment 
required (surgery, radiation, chemotherapy) 
altered body structure or function quality of 
psychological support provided by oncology 
staff.   
 
The cancer-derived factors that affect adaptation to cancer are related to 
characteristics of the disease itself, such as stage of the disease, symptoms, site, 
prognosis, type of treatment, and the impact in functionality.(22)  
The estimate of the prevalence of psychiatric disorders in persons with 
chronic medical illnesses is of considerable importance for several reasons.  
1. The psychiatric disorders complicate the clinical assessment of 
chronic medical diseases.  
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2. The primary care physician may not always detect the psychiatric 
disorders in patients with medical diseases.(23) 
3. Treatment of the two types of disorders may be complicated by 
drug interactions.(24)  
4. The coexisting psychiatric disorders could increase both the 
utilization of services and disability of persons with chronic 
medical conditions. 
  Studies have determined that 5.9% of ambulatory primary care patients 
suffer from Major Depressive illness. Affective disorder found to occur in 22% 
to 33% of patients with medical illness in inpatient medical units. (25).   
In a large community study, patients with or without one of the eight 
chronic medical disorders were compared on the basis of prevalence of 
psychiatric illnesses. The result showed that patients with one or more chronic 
illnesses had a 41% increase in the relative risk of having any psychiatric co-
morbidity. The affective, anxiety and substance use disorders were more 
prevalent in persons with chronic medical conditions. (26)    
Depression is common in medically ill patient as an affective disorder, as 
a symptomatic complaint or as a clinical syndrome and the presence of major or 
minor depression in medically ill patients has significant effect on patients 
morbidity and mortality.(27) Diagnosing major depression in medically ill 
patients historically has been an area fraught with controversy.  
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Cohen Cole et.al reviewed the four approaches to diagnose major 
depressive disorder in medically ill. (28)  
They are as follows:  
1.  Inclusive Approaches: which include all symptoms and signs 
presented by the patient, whether or not they may be secondary to 
physical illness. This approach leads to false positive. 
2. Etiological Approach: This attempt to operational guidelines of DSM-
IV. The clinician tries to determine whether the symptoms are 
secondary to physical illness.  
3. Substitutive Approach: This suggests changing the criteria for the 
diagnosis of depression in medically ill.  
4. Exclusive Approach: which eliminate anorexia and fatigue from the 
list of nine symptoms of DSM depressive criteria and require four of 
the remaining seven symptoms. 
CANCER: PROBLEM STATEMENT  
Cancer may be regarded as a group of disease characterized by :   
1. Abnormal growth of cells.  
2. Ability to invade adjacent tissue and even distant organs,  
3. The eventual death of the affected patient if the tumour has progressed 
beyond that stage when it cannot be successfully removed. Cancer can 
occur at any site or tissue of the body and may involve any type of cells.  
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The major categories of cancer are: 
1. Carcinoma, which arises from epithelial cells lining the internal surface 
of the various organs and from skin epithelium. 
2. Sarcomas, which arise from mesoderm cells of various connective 
tissues. 
3. Lymphoma, myeloma, leukaemia arising from cells of bone marrow 
and   Immune cells. 
EPIDEMIOLOGY OF PSYCHIATRIC DISORDERS IN CANCER 
PATIENTS 
The prevalence of psychiatric disorders in cancer patients is 
approximately 47 % Derogatis et al(3). More than two thirds of those represent 
adjustment disorders, 10 to 15 percent major depression, and about 10 percent 
delirium. The prevalence is highest among patients with advanced cancer and 
poor prognosis. 
In-patient studies show a higher incidence of 20% to 45% of depression 
and 15% to 75% of delirium. Studies of psychiatric consultation data reveal that 
treatable syndromes, such as major depression and delirium, continue to be 
under diagnosed and undertreated.  
In Indian study conducted by Chaturvedi et al.(29) had found that 38% of 
cancer patients had identifiable DSM-III anxiety or depressive disorders.  
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Another National study by Alexander et.al.(30) has found the prevalence of 
psychiatric morbidity to be 40 % of the study population. 
 Another study by Ashraff et al.(31) at the malignant disease treatment 
centre, AFMC Pune found out that 44% of patients had a psychiatric diagnosis.  
          In the study conducted by Mishra et al.(32) found 63% of patients to have 
psychiatric morbidity.  These points are towards the fact that the prevalence of 
psychiatric morbidity in Indian population is high. 
Prevalence of depression in medical settings 
Disorder Prevalence 
General population(33) 6.7% 
Primary care(34) 5-20.7% 
Emergency room(33) 7% 
General hospital (35) 26% 
Cardiology outpatients(36) 12-23% 
Cardiology inpatients 16-20% 
Endocrine outpatients(37) 12-18% 
HIV patients(38) 16.2-36% 
Oncology outpatients(39) 16.3% 
Neurology In-patients ,post CVA(40) 20% 
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INCIDENCE OF CANCER AND MORTALITY RATES  
Studies reported that the lifetime risk of developing cancer is less in men 
and more in women. Cancer stands the second most common cause of death 
after heart disease, accounting for one in every four deaths in united state. The 
5-years relative survival rate for all cancers diagnosed between 1996 and 2002 
is 66%  this has improved from 51% in 1975 to 1977.  
Prostate cancer in men and breast cancers in female are the most common 
type, but lung cancer is responsible for the highest rates of mortality in both 
groups. Lung cancer accounts for about 15 % of cancer diagnoses. 
The incidence rates of lung cancer have been declining in men since the 
1980; the incidence rates in women are approaching a plateau after a long 
period of increase. The 5year-survival rates for localized lung cancer are 49% 
and 16% of lung cancers are diagnosed in early stage.  
Incidence rates of prostate cancer have changed substantially over the 
past 20 years, rapidly increasing from 1988 to 1992, declining sharply from 
1992 through 1995, and modestly increasing since 1995. These trends largely 
reflect increased prostate cancer screening with prostate specific antigen (PSA) 
blood testing. 
Death rates from breast cancer in women have decreased since 1990s due 
to a combination of earlier detection and improved treatment. 
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Colorectal cancer is the third most common cancer in both men and 
women. The incidence of colorectal cancer has decreased over the past two 
decades with screening colonoscopies, through removal of polyps. 
GLOBAL BURDEN OF CANCER INCIDENCE AND MORTALITY IN 
2000(41)  
Site Incidence Mortality 
 Male Female Male Female 
Lung 901 337 810 292 
Breast - 1050 - 372 
Colorectal  498 445 254 237 
Stomach 558 317 405 241 
Liver 398 165 383 164 
Prostate 542 - 204 - 
Cervix - 470 - 233 
Esophagus 278 13 226 110 
Bladder 259 76 99 110 
Lymphoma 166 120 93 67 
Oral cavity 169 97 80 47 
Leukemia 144 112 109 85 
Pancreas 115 100 11 101 
Ovary  - 192 - 114 
Kidney 118 70 56 35 
Source: WHO (2003), world cancer report, By Bernald W.Stewart and Paul 
Kleihues.  
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The global burden of cancer incidence and mortality is shown in terms of 
incidence, the most common cancer worldwide is lung cancer 12.3% and breast 
cancer is 10.4%, and colorectal cancer is 9.4%. 
EPIDEMIOLOGY OF CANCER IN INDIA 
In India the most common site of cancer in men is respiratory tract cancer 
and in women is cervical cancer. Among Indian women, cancer of cervix and 
breast account for nearly 60% of all cancers. (42) 
PSYCHATRIC MORBIDITIES IN CANCER: 
The diagnosis of cancer causes stress, on any individual which relates 
both to symptoms of disease and to the psychological meaning attached to 
cancer. The patient ability to manage these stresses depends on the prior level of 
emotional adjustment, threat the cancer posses to attainment of age appropriate 
goals (example:  career, starting a family, retirement), the presence of 
emotionally supportive person in the environment and variable determined by 
the disease itself (disability symptoms, site of cancer, treatment required, 
presence of pain, and prognosis). (21) 
The commonest reaction observed in the cancer patients is depression, it 
was considered as the only emotional response to cancer.  Most of the earlier 
literature on psychiatric co-morbidity of cancer was from clinical experience or 
instructed interviews with patients and was largely anecdotal.  There are 
considerable methodological problems in assessing the psychiatric co-morbidity 
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among cancer patients.  This including medical professionals, view cancer as 
dreaded condition, a condition that tantamount to a death sentence. This is rated 
in the results of studies in which medical professional’s were found to have 
rated cancer as a conditions which is more worthless than death. (43,44)  
A patient with cancer is expected to have a certain level of psychological 
distress.   Despite these difficulties, a majority of the studies have revealed a 
significant level of psychiatric co-morbidity among cancer patients.  A study 
conducted on out-patients cancer population reported 34% to have a clinically 
significant level of psychological distress.  In another study, of cancer patients 
admitted to three centres in USA, also revealed similar results. (45)  These studies 
found Adjustment disorder as the commonest psychiatric syndrome in cancer 
patients, with major depression, delirium and anxiety diodes as the next 
common diagnoses.  Condition like personality disorders, psychoses and 
substance abuse are comparatively infrequent.   
In the Indian population,  study conducted by Chaturvedi et al (46), 38% of 
cancer patients were found to have identifiable DSM III-R anxiety or depressive 
disorder. Earlier studies did not differentiate the psychiatric morbidities related 
to different types of cancer.  Differential effects of other factors like, the impact 
of the diagnosis, stage of disease and the type of the treatment were also not 
emphasis in these studies.  The early stage of the disease, it is the impact of the 
diagnosis and the treatment which have most psychological effects and in 
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advanced disease, the physical symptoms and impending death assume 
importance.   
EFFECT OF CANCER 
Psychiatric symptoms sometimes occur due to the direct effect of the 
disease process.  Psychiatric symptoms are seen in almost all patients with 
supra-tentorial tumours and are the presenting symptoms in 25% of case (45) a 
common presentation of carcinoma of pancreas is with depression. (46) 
 Physiologically active tumours of endocrine glands (like thyroid, 
pituitary and parathyroid), can also manifest as psychiatric syndromes.  In the 
advanced stage, cancer can produce psychiatric symptoms by metastatic lesions 
and other modes, as in paraneoplastic syndrome. 
 
IMPACT OF DIAGNOSIS 
Diagnosis of cancer evokes a greater emotional reaction than diagnosis of 
any other disease, regardless of mortality of cancer or cancer treatment 
modality.  Shock and disbelief are the commonest initial responses, followed by 
anger, depression and a feeling of loss or grief.  The normal reaction can vary 
from person to person.  The intensity and duration of emotional distress and the 
degree to which interferes with patients life seems to determine whether the 
emotional response is normal or abnormal.  Chakravorty et al. in a meta-
analysis of 13 studies on the prevalence of denial, diagnosis in cancer found out 
31 
 
that the prevalence of denial varied from 4.3% to 46.7% which is highly 
variable(47). 
Following the diagnosis of cancer, patients may have features of anxiety 
or depression.  These psychiatric symptoms may persist for variable period, if 
left unmanaged.  Women, who undergo screening for breast cancer or cervical 
carcinoma, may also develop significant levels of anxiety and depression who 
were waiting for the result.  The sources of continuing emotional distress are 
fear of incurability, pain, disfigurement, recurrence of disease, and sense of 
helplessness over its treatment.  Cancer may affect the family in similar way as 
it invades the body of the patients (48) and cause psychosocial distress or anxiety 
and depression among the family member also. 
 
MORBIDITY ASSOCIATED WITH TREATMENT MODALITIES.   
Differentiation of psychiatric morbidity related to cancer as such or from 
treatment is unclear.  The three forms of treatment available (surgery, 
chemotherapy and radiotherapy) or age-associated psychiatric co-morbidity.  
Psychiatric co-morbidity with cancer therapies ranges from 18 to 40 %(49).  
SURGERY  
Surgery often generates fear of procedure and grief over the surgically 
removed body parts.  Mastectomy is the surgical treatment which has been 
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studied extensively.  Anxiety, depression and sexual problems were found in a 
substantial minority of patients who had undergone this treatment (49,50).   
In the study conducted by Maguire et al.(50) Women with breast cancer 
were followed up for one year after the surgery.  The anxiety symptoms noted 
were persistent tension, inability to relax, palpitation and panic attacks.  Around 
one third of the patients had sexual problems also.  They had either abstinent 
intercourse or ceased to enjoy it.  Husbands of mastectomy patients also 
reported that decrease in sexuality and intimacy over the severely affected areas 
following the surgery (wellish DK et al).(51). Other problems reported in this 
area were disturbances in body image and a feeling of personal inadequacy (52). 
Ray et.al(53) reported the persistence of concerns regarding disfigurements for 
several years after the surgery.  Subsequent studies confirmed these findings 
except one. (54) 
Though the initial reports blamed mastectomy as the sole cause of the 
psychiatric co-morbidity.  Later studies, comparing the psychiatric morbidity of 
mastectomy patients undergone conservative surgery, revealed that breast 
conservation did not categorically eliminate psychiatric problems.(55) Anxiety  
levels, in fact, were found to be little higher in the recovery phase, among 
patients who underwent conservative surgery,  mastectomy group was different 
only in the negative body image and experienced , more intense and persistent 
negative feeling about their bodies. 
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Colostomy, laryngectomy and hysterectomy are the other surgical 
treatments studied in this respect.  Colostomy patients had significantly more 
depression, sexual dysfunctions and other social problems than patients 
undergoing bowel resection without colostomy. (56, 57)  Depression, anxiety, and 
disturbances in familial and social relationships have been noted as main 
problems in laryngectomy patients.(58,59)  In a comparison of preoperative and 
post operative laryngeal and oral cancers in India (Chaturvedi SK et al) (59) 
concerns about speech and communication were reported to be 76% of 
laryngectomy following surgery.   
Mastectomy, permanent colostomy, maxillofacial surgery and 
hysterectomy have been reported to produce immense psychological impact on 
patients, like depressive illness, psychosexual problems and social problems 
(isolation, loneliness, decreased social visits), drinking and occasionally suicide.   
RADIOTHERAPY  
Radiation treatment is associated with highly unpleasant side effect.  The 
side effects includes nausea, vomiting and increased fatigue.  A prospective 
study done by Schmale et al.(60)  patients receiving radiotherapy had shown 
significant psychiatric problems in the first three months.   Different authors 
have tried to correlated the psychiatric problems to the common side effect of 
radiotherapy(61,62) the fatigue, usually seen in radiotherapy patients, had a high 
correlation with psychiatric co-morbidity.  Radiotherapy has also been reported 
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to cause nausea, a peculiar deserving kind of fatigue, poor psychosocial 
adjustment, unrealistic expectation about the outcome, and non-engagement 
with the physician. (63) .  Chaturvedi et al. in a prospective study showed the 
levels of anxiety and depression in patients receiving radiation treatment in 
India.  Anxiety and depressive disorders were detected frequently, both prior to 
treatment and later during follow up.  Frequency of anxiety increased 
significantly after initiating radiotherapy, but later reduced during follow up 
assessment after a few months.   
CHEMOTHERAPY  
In some of the Neoplastic disorders, like Wilms tumour or Hodgkin 
disease, chemotherapy produces dramatic improvement.  But most often the 
prolongation of life is achieved at the cost of Quality Of Life.  The studies done 
by Morris et al (64) in this area, which judge outcome solely on the basis of 
survival, ignore quality of life (QOL) and psychiatric co-morbidity.  This 
reflected in the result of the study which reported the quality of lives of patients 
receiving multiple chemotherapeutic drugs as unsatisfactory. The psychiatric 
co-morbidity related to chemotherapy has been studied extensively in patients 
with breast cancer.  Adjuvant chemotherapy in mastectomy patients was found 
to be associated with a significant increase in the incidence of depression, 
anxiety and sexual problems.  
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Hughson et al.(65) found that chemotherapy in patients with breast cancer 
was associated with greater psychiatric co-morbidity than radiotherapy.  In one 
study,(66)  by Meyerowitz et al. the overall level of psychological distress did not 
significantly correlate with physical side effect of treatment.  Silberfarb et al.   
studied two groups of patients with small cell carcinoma of lung, receiving 
different chemotherapeutic agents, and found that the patients receiving vinca 
alkaloid had a  higher incidence of psychiatric problems.   
All chemotherapeutic agents can produce organic psychiatric syndromes.  
The various psychiatric problems produced by the commonly used 
chemotherapeutic agents are listed below. 
Drug causing Psychiatric symptoms 
Mood symptoms Anxiety Halluncinations  Delirium 
Vinblastine, 
dacarbazine, 
vincristine, L-
aspaginase, 
Interferon 
Interferon Vincristine, 
hydroxy urea 
All the 
chemotherapy 
agent. 
  
Chemotherapy can produce nausea and vomiting as the immediate side 
effects.  Though various chemotherapeutic agents vary in this vomiting potency, 
almost all have side effects. After an initial episode of nausea and vomiting, 15 
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to 65% of patients develop anticipatory nausea and vomiting. (45)  Becomes so 
severe that they cannot continue treatment.  Patients may also develop a 
conditioned response when exposed to sight and smells reminiscent of 
chemotherapy experience. Lung cancer patients receiving palliative 
chemotherapy were found to have depression and communication problems 
than those receiving no treatment at all.(67)  In this case chemotherapy may 
promote a feeling of optimism.  Maguire et al. noted that chemotherapeutic 
agents caused fatigue, nausea and irritability, along with adverse effects on the 
sexual life.  Vinca alkaloids are especially known to cause depression. 
Holland et al in 1993 has summed up the meaning attached to cancer as 
five D’s as: Death, Disability, Disfigurement, Dependence, and Disruption of 
relationship. A study done by Latha et al(68) has revealed that thought evoked in 
person on first hearing that they have cancer, will provoke fear of physical 
dependence (98%) fear of treatment (80%), fear of death (64%), fear of pain 
(62%), and fear of recurrence (62%).  
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PREVALENCE OF PSYCHIATRIC DISORDER IN CANCER 
PATIENTS 
DEPRESSION AND ANXIETY 
 Prevalence studies in cancer patients have predominantly focused on 
affective symptoms. Few have investigated for cognitive dysfunction (69,70) and 
other psychological issues. (71).   A landmark study done by Derogatis et al. 
investigated the association between cancer and psychiatric co-morbidity.  In 
this study 215 randomly selected cancer patient who were new admission to 
three centres were examined for the presence of psychiatric co-morbidity. Each 
patient was assessed in a common protocol by a psychiatric interview. The 
patients were examined as per the diagnostic categories of DSM-III. Results 
indicated that 47% of the patient received a DSM-III diagnosis.  (44% being 
diagnosed as manifesting a clinical syndrome and 3% with personality 
disorder).  68% of the psychiatric diagnosis (adjustment disorder with 
depression, anxiety or mixed mood. 13% presented with major affective 
disorder, 8% had organic psychiatric disorder, 4% had anxiety disorders and 7% 
had personality disorder). In the study, 85% of these patients with positive 
psychiatric condition were experiencing a disorder with depression or anxiety as 
a central symptom (3).  
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Other studies, investigated the prevalence of psychiatric disorder in 
cancer patients are summarized below. 
PREVALENCE OF PSYCHIATRIC DISORDERS 
 IN CANCER PATIENTS. 
Study Sample 
population  
Prevalence  Assessment 
methods 
Craig (1974) 30 leukemia and  
Lymphoma 
patients 
Anxiety in 30 % 
patients. Severe 
depression in 23% 
Self administered 
questionnaire and 
symptom check 
list 90 
Levine (72)(1978) Mixed 100 
medical  
And surgical 
oncology patients. 
Patients referred 
to psychiatric 
consultation  
Depression in 
56% patients ,0nly 
10%of depressed 
patients had CNS 
metastasis 
Psychiatric 
interview 
diagnosis as per 
DSM-III 
Hughus(63) (1982) 44 patients early 
breast cancer who 
underwent 
mastectomy  
Pre-masectomy 
anxiety symptoms 
in  25% and post-
mastectomy 
60 items GHQ 
using  cut of >11 
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depressive 
symptoms in18 % 
Farber (73) (1984) Out patients 141 
breast cancer 
Clinically relevant 
psychological 
distress 18% had 
severe, and 21 % 
had moderate 
Hopkins symptom 
check list 
Bukburg and 
Holland (74) (1984) 
Hospitalized 
cancer patients  
Severe depression 
24%, moderate 
depression 18%, 
14% had sadness, 
44% had no 
depression 
DSM-III criteria 
with elimination 
of physical 
symptom 
Hamilton 
depression scale 
and beck 
depression 
inventory. 
 
In summary, adjustment disorder with depressed mood and major 
depression account for the majority of diagnosis. The prevalence of major 
depressive disorder in general population obtained from large community 
studies was 2-4%.(75,76)  The number is more if the  population studied is derived 
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from primary care setting with prevalence ranging from 4.8 to 9.2 % in 
ambulatory patient.(77) 
The rate increases further among medical in-patients ranging between 27-
33%. Magni et al. in 1986 used a structured psychiatric interview and found that 
8% of the 220 geriatric medically ill in-patients suffered from major depression, 
22% had dysthymia and 6% had atypical depression.(78). The prevalence of 
major depression increases on comparing community, primary care, inpatients 
and severely medically ill patients. Several studies have confirmed the 
prevalence of depression in cancer patients in between 20 and 50%.  
Some of the representative studies are summarized below. 
PREVALENCE OF DEPRESSION IN CANCER PATIENTS 
Study No. and type of cancer Depression 
Fras et.al(79)(1967) 47 Carcinoma pancreas 50% 
Koenig et al (80) (1967) 36 carcinoma colon 25% 
Devlin et al (81)(1971) Carcinoma colon 25% 
Morris et al (52) (1977) 69 carcinoma breast  22% 
Maguise et al (50)(1977)  75 carcinoma breast  
Preoperative 
 Postoperative 
 
13% 
27% 
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Study No. and type of cancer Depression 
Plumb and Holland et 
al(82)(1981) 
97 mixed cancer patients  24% 
Evan et al (83) (1986) 83 Gynaecological cancer 23% 
Kathol et al (1990) 808 mixed cancer 25%-38% 
Llyod Williams et al (84) 
(2002) 
72 mixed advanced cancer  26% 
Hotopf et al (85) (2002) A systematic review of 46 studies 
on advance cancer 
29% 
Llyod williams et al 
(86)(2004) 
74 mixed cancer 27% 
Pandey et al (87) (2007) 123 head and neck cancer  11% 
 
 Depression in cancer patients result from stress related to cancer 
diagnosis and treatment, medications, biologically determined depression not 
related to precipitating events, and recurrence of bipolar mood disorder. A 
variety of other factors like past history of depression or suicidal attempts, 
history of alcohol dependence and other substance abuse, presence of neurotic 
traits, recent grief and frequent negative life events could also predispose to 
depression. (88) These facts make us to realize the necessity of prompt 
assessment and management of depression in cancer patients.  
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Advanced cancer patients who are depressed may also have physical 
symptoms which are difficult to palliate and these symptoms improve as their 
depression is treated.(86) Depressed cancer patients have been found to have 
higher than normal level of interleukin-6 pro-inflammatory cytokine. This could 
explain the presence of increased physical symptoms in this population. 
SUICIDE AND CANCER 
Although few cancer patients commit suicide, they may be at somewhat 
greater risk than the general population. (89,90) Passive suicidal thoughts are 
relatively common as patient battle a life-threatening illness. These thoughts 
provide a sense of control in those overwhelmed by suffering, uncertainty and 
helplessness. Below explains the risk factor for suicide in cancer.(91) 
Risk factor for suicide in cancer patients  
Personal Male gender, prior history of depression or suicidal attempt, prior 
psychiatric disorder, prior alcohol or drug abuse/dependence, 
depression and hopelessness, social isolation 
Medical Pain, delirium with poor impulse control, advanced stage of 
disease, exhaustion, fatigue.   
  
Studies by Cousin JP et al. have shown that suicidal depression has been 
associated with some chemotherapy treatment.(92) Patients with head and neck 
cancer are at slightly increased suicidal risk, since tumour in the mouth and the 
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pharynx are associated with alcohol and tobacco abuse which is often associated 
with pre-existing personality disorders.(93) Morbid preoccupation with suicide or 
ruminative plans to commit suicide in cancer patients for whom the disease is in 
remission or in whom a good prognosis exists require careful evaluation.(94) A 
review of all suicide in Finland in 1 year, revealed that 4.3%of suicide cases had 
cancer. A treatable major depressive episode may be precipitating their suicidal 
ideation.(95) Chochinav et al. studied the persistent desire for death in the 
terminally ill is closely associated with depression and it is particularly 
important to evaluate for the presence of hopelessness, which is a better 
predictor of suicidal risk than depression itself.(96) Louhivouri et al. and Hakama 
et al. studied 28,000 patients with cancer and found a 1.3 times greater risk for 
male and a 1.9 times greater risk for female patients. The highest risk was seen 
among patients who were not undergoing treatment. (97) 
ADJUSTMENT DISORDER 
This is the commonest psychiatric disorder seen in cancer patients.  
Derogatis et al.  reported prevalence as 68% in their study population.  The 
diagnosis of cancer may precipitate adjustment disorders which may be 
associated with depressed mood, anxious mood, and mixed emotional features. 
Diagnosis of cancer may lead to a normal stress reaction. But these patients use 
their normal coping mechanisms to correct their stresses, without functional 
impairment. Patients with poor coping skills land up with adjustment disorder. 
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In a study in Indian population conducted by Gopalan MR et al.98 conclude that 
41.7% had psychiatric disorders. Adjustment disorders were seen in 22.6%, 
10.9% of subjects had major depressive disorder. Total of 33.5% of patients had 
diagnosis of Anxiety or depression. Adjustment disorder is most common 
psychiatric morbidity among the cancer patients. 
The following are therapeutic indictors of poor coping skills; 
• Those with previous history of psychiatric illness,  
• Patient who belong to low educational and economic status, 
• Patients with poor social support, 
• Patients in the later stages of illness.  
Hence a good rapport is ultimately needed to recognize, if the distress is 
due to the illness as such or due to underlying psychodynamic issues. Usually 
adjustment disorder gets resolve with the subsidence of the stressor. Some 
patients may need medications and counselling. (Kaplan and Sadock, 2009). (19) 
ORGANIC PSYCHIATIC SYNDROME 
The commonest organic psychiatric syndrome in the cancer patients is 
delirium.(45) Delirium can be produced either by cancer directly and its 
treatment, or because of associated psychiatric disorders and their treatment.  
Metabolic Encephalopathies, organ failure, electrolyte imbalance, nutritional 
deficiencies, infection and hypoxia are some of the medical disorders causing 
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delirium.  Besides delirium, other organic psychiatric syndromes like dementia 
are also seen in cancer patients.   
PSYCHOSIS  
Schizophrenia and other functional psychosis are comparatively less 
frequent than the other above mentioned disorders, but contrary to the earlier 
beliefs, cancer is not rare in schizophrenic patients than in general populations.  
OTHER PSYCHIATRIC DISORDER 
Other psychiatric syndromes worth mentioning are substance abuse 
related problems, like alcohol, narcotic and other drug withdrawal syndromes, 
and somatoform disorders.  Presence of a somatoform disorder in cancer can 
create management problems resulting either in delaying the treatment or over 
treating psychosomatic disorders. (99,100). 
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AIMS AND OBJECTIVES 
To assess the Psychiatric disorder as co-morbidity in a group of cancer 
patients, attending a tertiary care hospital for the treatment. To assess the 
Typology and Frequency of Psychiatric co-morbidity. 
OBJECTIVES  
The present work is being undertaken: 
1. To study the frequency, type and Psychiatric disorder as co-morbidity in 
cancer patients attending the tertiary care hospital. 
2. To assess the correlation of psychiatric morbidity among the socio-
demographic variables. 
3. To assess the correlation of psychiatric morbidity and duration, nature 
and typology of cancer.  
4. To study the correlation between psychiatric co-morbidity and Treatment 
variables.  
HYPOTHEISIS 
The following null hypothesis was postulated.  
1. Patients with cancer have high prevalence of psychiatric morbidity than the 
general population. 
2. The prevalence of psychiatric morbidity is higher in women with poor social 
support and lower education status. 
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3. The prevalence of psychiatric morbidity is higher in patients with longer 
duration of illness.  
4. The prevalence of psychiatric morbidity is higher in patients in the later 
stages of illness.  
5. Depression is the more prevalent in the patients receiving the radiotherapy 
treatment. 
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MATERIALS AND METHODS 
Setting: 
The study was conducted in the Patients, who attending the outpatient clinic 
and admitted in wards for the treatment of cancer, in the Department of 
Radiotherapy, Medical Oncology ward and Surgical ward, Thanjavur Medical 
College Hospital. 
Study Design:  
A “Cross Sectional – Descriptive Study Design” was used in this study.  
Duration of Study: 
Between the period of “January 2017 – June 2017”. 
Duration of study is 6 months.  
Recruitment of Patients: 
 Consecutive Sample of 100 patients was selected for the study, those who 
attended the clinic in the Department of Radiotherapy, Surgery, and Medical 
ward for the treatment of cancer, Thanjavur Medical College, during the period 
of January 2017 – June 2017. Those who fulfilled and satisfied the inclusion 
criteria and willing for the study were selected.  
Inclusion criteria: 
1. Patients in the age group of 18 – 65 years. 
2. Histologically  proven cases of carcinoma.(ICD 10-C50)  
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 3. Patients who were aware of their diagnosis. 
 4. Those who are willing for the study. 
Exclusion criteria:  
1. Patients below 18 years and above 65 years of age. 
2. Patients with history of Psychiatric illness and on treatment before the 
onset of disease. 
3. Patients who are in the immediate post-operative period and patients with 
severe physical illness.  
4. Patients with Brain and Endocrine cancer (Thyroid, Parathyroid, 
Thymoma, Pituitary) are excluded. 
5. Patients those who were unaware of the diagnosis and those who were 
unwilling for the study. 
METHODOLOGY 
 A sample of 100 patients diagnosed with carcinoma who were attending 
OP/IP in Radiotherapy ward, medical and surgical ward were selected, assessed  
and included for the study. 
OPERATIONAL DESIGN: 
1. The study was been conducted at Thanjavur Medical College & Hospital, 
duration of 6 months, between the period of January 2017 to June 2017.  
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2. The study was approved by Institutional Ethical Committee, Thanjavur 
Medical College Hospital. 
3. The sample was chosen those who attended Surgical, Medical and 
Radiotherapy OP/IP. 
4. Every consecutive patient who met the inclusion and exclusion criteria 
were selected, and included in the study. 
5. The subjects were explained about the nature of the study and informed 
consent was obtained from them.  
6. Semi- structured proforma was used to collect the Socio Demographic 
details. 
7.  A Complete Physical Examination including Neurological Evaluation 
and detailed Mental Status Examination was done to all the selected 
subjects.  
8. All subjects were assessed by General Health Questionnaire -12 (GHQ-
12). 
9.  All subjects were assessed by MINI International neuropsychiatric 
interview for diagnosing psychiatric disorder and based on the diagnosis 
specific scales like Hamilton depression rating scale, Hamilton anxiety 
rating scale were administered. 
10. All subjects were assessed by Kuppuswamy rating scale for socio  
economic status. 
11. Likewise 100 consecutive patients were assessed. 
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Statistical design: 
Statistical design was formulated using the data collected as above, for 
each of the scales and socio-demographic variables percentage analysis and 
descriptive analysis were used.  The central values and dispersion were 
calculated. In comparison of the data for categorical variables chi-square were 
used. For multiple comparisons of more than two numerical variables, one way 
ANOVA and “f ” tests were used.                    
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TOOLS USED 
1. Semi – Structured Proforma 
2. General Health Questionnaire -12 (GHQ – 12)(101) 
3. MINI international neuropsychiatric interview. 
4. Hamilton depression rating scale.  
5. Hamilton anxiety rating scale. 
6. Kuppuswamy rating scale for socio economic status.(102) 
TOOLS USED 
1. Semi – Structured Proforma: 
Proforma includes personal socio-demographic details, Age, Sex, 
Religion, Marital status, Education, Occupation, Region, Socio Economic 
Status and social support were collected. 
 Time interval between knowledge and aware of illness, mode of  
treatment for cancer , number of chemotherapy and radiotherapy given, duration 
of last treatment, personal history, past history, family history, substance and 
drug history, medical co-morbidity, Mental  status examination. 
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2.General Health Questionnaire – 12: 
The GHQ was designed by Goldberg et al(101) (1972) in order to identify 
psychiatric morbidity in general practice. It is a self administered questionnaire, 
referring to recent symptoms, and require 10 minute for the subject to complete 
it. The questionnaire provides information about the recent mental status, thus 
identifying the presence of “possible psychiatric disturbances”. However it 
neither provides information about the personality of the respondent, nor have 
any predictive value. The reliability and validity are established by the author. It 
become less useful when respondents are too defensive, patients suffering from 
dementia, or chronic schizophrenia. Similarly it may give erroneous inference if 
used on chronic patients during the ‘good’ phase of their illness. Twenty and 
twelve item questionnaires are designed from the original GHQ without losing 
the reliability and validity. The 12 item GHQ has a reported sensitivity of 95% 
and specificity of 88% (Goldberg 1972). The shorter version of the 
Questionnaire is less likely to be refused, and takes less time to be completed, 
and hence was used in this study. Each item in the test consists of a question 
asking whether the respondent has recently experienced a particular symptom, 
or item of behaviour, on a scale ranging from ‘less than usual’ to much more 
than usual’. The questionnaire starts with items with somatic, symptoms, since 
it is presented to the respondents as a general health questionnaire, as one 
proceeds, the symptoms become more overtly psychiatric and potentially more 
disturbing. 
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3.MINI international neuropsychiatric interview : 
The M.I.N.I. is a structured interview for diagnosing the major Axis I 
psychiatric disorders in DSM-IV and ICD-10.The interview is short and takes 
about 15 minutes to administer. It can be administered after a brief training. It is 
a useful instrument in epidemiological studies and trials. It has precise questions 
about psychological problems and the answers are in yes or no format. The 
M.I.N.I. is divided into 16 modules identified by letters, each corresponding to a 
diagnostic category. M.I.N.I has been validated against the much longer 
structured clinical interview for DSM diagnosis (SCID-P) in English and French 
and against the composite International Diagnostic Interview for ICD-10(CIDI) 
in English, French and Arabic. It has also been validated against expert opinion 
in a large sample in four European countries (France, United Kingdom, Italy 
and Spain). Validation and reliability on comparing with several structured 
interviews were found to be good. 
 
4.The Hamilton Rating Scale for Depression (HAM-D): 
The Hamilton Rating Scale for Depression (HRSD) also called the Hamilton 
Depression Rating Scale (HDRS), or HAM-D. It is one of the most popular 
depression assessment instrument in the field of clinical and health psychology. 
It is a questionnaire with multiple items. It is used to evaluate depression and its 
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recovery. Max Hamilton published the scale in 1960 and was revised in 1966, 
1967, 1969, and finally1980.  
It is designed exclusively for assessment of depression in adults. The 
severity of depression is rated based on the prevailing mood, guilt feelings, 
suicide ideas, sleep disturbances, agitation or retardation, loss of weight and 
somatic symptoms.  
It was considered the "Gold Standard" instrument for rating depression in 
research settings. But its use in clinical practice criticized because of over 
emphasize on insomnia than on suicide ideas and gestures. Hence this scale 
should not be used for diagnostic purpose. 
The original version of this scale published in 1960 contains 17 items 
(HRSD-17). Each item is scored on a 3 or 5 point scale, and the total score is 
rated. It is assessed in 20 minutes. The 21 item scale includes four more items 
namely (diurnal variation, depersonalization/de-realization, paranoid symptoms 
and obsession and compulsion symptoms). Another 24 item version contain 
three more items namely; helplessness, hopelessness and worthlessness (Paykel, 
1985, Rosenthal and Klerman, 1966). 
Many psychometric properties of this scale are adequate and meet the 
needed criteria. The internal, inter-rater, and retest reliability is good. At the 
item level the inter-rater and re-test coefficients are weak for many items. But 
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this is not considered as a terminal flaw. Whether the items as a whole provide 
adequate reliability is the determining factor. 
5.Hamilton Rating Scale for Anxiety (HAM-A): 
The Hamilton anxiety rating scale is one of the widely used rating scales 
for assessment of severity of anxiety. It was first devised by Max Hamilton 
in1959. It is a clinician rated scale and has an administration time of 10 to 15 
minutes. It is a semi-structured scale but structured interview guide is available. 
It has a good sensitivity to change during anxiolytic treatment. It has 14 items, 
each one of which is defined by a series of symptoms.  
The scale measures both psychological and somatic anxiety. All the items in the 
scale are scored from 0 (not present) to 4(severe). The total score ranges from 0 
to 56. Less than 17 indicate mild anxiety. 18 to 24 indicate mild to moderate 
anxiety and 25 to 30 indicates moderate to severe anxiety. Total above 30 
indicates very severe anxiety. Administration of the scale takes about 10-20 
minutes. HAM-A scale has been translated into Cantonese for China, and also 
in French and Spanish. 
6.Kuppuswamy socio economic status scale: 
Kuppuswamy scale is widely used to measure the socio-economic status 
of an individual based on three variables namely, education, occupation and 
income. It was originally proposed in 1976. It consists of ten categories are 
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grouped with 5 social class namely very high, high, upper middle, lower middle 
and very low. (S.E.Gupat, B.P.Sethi et al, and Kuppusamy 1961). Socio 
Economic Status (SES) is recognized determinant of wellbeing. Kuppuswamy’s 
socioeconomic status scale is an essential tool in hospital and community based 
research in India. The scale was revised in 2012 were the monthly family 
income was modified based on current consumer price index.(BP Ravi Kumar 
et al, 2012). 
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RESULTS 
Table – 1: Socio Demographic Variable among cancer patients 
Socio demographic variable Cancer patients (N=100) 
No. of 
respondents 
(n=100) 
Percentage 
(100%) 
AGE(in years)   
a) 18 to 35yrs 20 20.0 
b) 36 to 49yrs 46 46.0 
c) 50 to 65yrs 34 34.0 
SEX   
a) Male 38 38.0 
b) Female 62 62.0 
Marital status   
a) Married 98 98.0 
b) Unmarried 2 2.0 
Religion    
a) Hindu 90 90.0 
b) Christian 3 3.0 
c) Muslim 7 7.0 
Socio Economic status   
a) Upper  0 0 
b) Upper middle 2 2.0 
c) Lower Middle 54 54.0 
d) Upper lower 27 27.0 
e) Lower  17 17.0 
Type of family   
a) Nuclear type 87 87.0 
b) Joint type 13 13.0 
Domicile    
a) Rural area 88 88.0 
b) Urban 12 12.0 
Education    
a) Illiterate  53 53.0 
b) Primary school 37 37.0 
c) High school 2 2.0 
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d) Higher secondary 7 7.0 
e) Diploma/degree 1 1.0 
Occupation    
a) Skilled  5 5.0 
b) Semi skilled 17 17.0 
c) Unskilled  13 13.0 
d) Unemployed 65 65.0 
Substance use   
a) Tobacco  29 29.0 
b) Alcohol and smoking 34 34.0 
c) No substance 37 37.0 
 
Table – 1 : A total of 100 patients diagnosed with malignancy were included for 
the study.  Patients’ age ranged from 18 to 65 years with the mean age of 
48.29 years and the median age is 49 years.  Among the 100  cancer 
patients 38 (38.0%)  were males and 62(62.0%) were females, majority of 
them belong to the age group of 36 – 50 years  (46.0 % ) , 34.0% of 
patients belong to 50 – 65 years and remaining 20.0%  belong to 18 – 35 
years group. Among them 88.0% patients were from rural area and 
remaining 12.0% were from the urban locality. Considering the education 
status 53% patients were illiterate and 37% of  patients were studied 
primary school.   2.0%  studied up to high schools and 7.0% finished 
higher secondary education only one of them completed degree.  
Regarding the occupational status, 65.0% were unemployed, 17.0% were 
employed in semi skilled jobs, 13.0%  under unskilled and 5.0%  were 
skilled workers. Among the study groups 54.0% belonged to lower middle, 
2.0% from the upper middle, and 27.0% were from upper lower and 17.0% 
 were from the lower socio economic status. Majority of them were married 
(98.0%) and only 2.0% were unmarried. Most of them (87.0%) belonged to 
the nuclear family and remaining (13.0%) belonged to joint family. Among 
the cancer group 29.0% 
form of chewing and smoking, where as 34.0% had past history of alcohol 
and tobacco.  The remaining 37.0% were not exposure to any kind of 
substances in the past. 
Figure – 1: Age distribution among the 
 Figure -1 shows majority of patients belong to the age of 36 
(46.0 % ) , while 34.0% of patients belong to 50 
are 18 – 35 years of age.  
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TABLES- 2: SITE OF CANCER IN SAMPLE POPULATION 
LOCATION  
Sample size 
N=100 
Percentage 
% 
Head and Neck Cancer 32 32.0% 
Thorax 23 23.0% 
GIT 13 13.0% 
Genito -Urinary System 26 26.0% 
Haematological Malignancy 3 3.0% 
Skin 3 3.0% 
Total 100 100.0% 
 
Table 2: shows the distribution of patients according to the site of cancer. 32 
patients with head and neck cancer,23 patients with thoracic cancer, 13 patients 
with GIT cancer,  3 patients with hematological malignancy and 3 patients with 
skin cancer. 
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TABLE 3: TOTAL GHQ-12 
 
TOTAL GHQ 
N 
Valid 100 
Missing 0 
Mean 16.17 
Median 17.00 
Std. Deviation 5.021 
Minimum 1 
Maximum 27 
 
Table 3: shows the mean score of 16.17 in GHQ-12, median score is 17.00 with 
minimum score 1 and maximum of 27 among the cancer patients.  
TABLE – 4: PREVELANCE OF PSYCHIATRIC CO-MORBIDITY IN 
SAMPLE POPULATION 
Psychiatric disorder Sample size(n=100) Percentage (100%) 
Yes  58 58.0 
No 42 42.0 
 
Table-4 shows about 58 patients had psychiatric disorder and remaining 42 
patients were without psychiatric disorder among the cancer patients. 
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TABLE 5: DIAGNOSTIC ENTITY OF PSYCHIATRIC CO-MORBIDITY 
AMONG THE SAMPLE POPULATION 
MINI PLUS Diagnosis 
SAMPLE  
SIZE 
N=58 
Percentage 
Depression 16 27.6% 
Dysthymia 3 5.2% 
Panic disorder 4 6.9% 
PTSD 2 3.4% 
GAD 6 10.3% 
Adjustment disorder 27 46.6% 
 
Table 5: shows Prevalence of psychiatric co-morbidity among the cancer 
patients. Majority of the patients had Adjustment disorder - 27(46.6%), 16 
(27.6%) had Depression, 3(5.2%)  patients had Dysthymia, 6 (10.3%) patients 
had GAD, 4 (6.9%) had panic disorder and remaining 2 (3.4%) patients had 
PTSD.  
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FIGURE – 2 : PREVALENCE OF PSYCHIATRIC MORBIDITY 
AMONG THE SAMPLE POPULATION
 
Figure 2: shows the prevalence of psychiatric morbidity among the sample 
population. Majority of the patients had Adjustment disorder of 27(46.6%), 16 
(27.6%) had Depression, 3(5.2%)  patients had Dysthymia, 6 (10.3%)patients 
had GAD, 4 (6.9%) had panic disorder and 2 (3.4%)had PTSD.  
TABLE 6: SEVERITY OF DEPRESSION ON HAM-D 
Ham-D 
DEPRESSIVE DISORDER 
(Depression and Dysthymia) 
N=19 Percentage % 
Mild 4 21.1% 
Moderate 5 26.3% 
Severe 5 26.3% 
Very Severe 5 26.3% 
Total 19 100.0% 
 
Depression, 16
Dysthmia, 3
Panic disorde, 4
PTSD, 2
NAD, 42
GAD, 6
Adjustment 
disorder, 27
Depression Dysthmia Panic disorde PTSD NAD GAD Adjustment disorder
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Table 6: shows the severity of depression on HAM-D score. Total of 19 patients 
were include both Depression Disorder and Dysthymia.  Among them 4 patients 
scored mild, 5 had moderate, 5 were severe and 5 patients scores very severe on 
Hamilton rating score for depression.   
TABLE 7: SEVERITY OF ANXIETY ON HAM-A 
HAM –A 
Anxiety disorder 
N=12 Percentage % 
Mild 2 16.7% 
Mild-Moderate 4 33.3% 
Moderate-severe 6 50.0% 
Total  12 100.0% 
 
Table 7: shows the severity of Anxiety on HAM-A.  Among the 12 patients(6 
patients GAD, 2PTSD, 4 panic disorder), 2 patients scored mild, 4 had mild to 
moderate  and 6 patients score between the moderate to severe anxiety on 
HAM-A. 
TABLE – 8 : DISTRIBUTION OF PATIENTS WITH MODE OF 
TREATMENT  
              Mode of treatment 
Sample size 
N=100 
Percentage 
% 
Radiotherapy 39 39.0% 
Chemotherapy 30 30.0% 
Surgery 31 31.0% 
Table 8:  shows distribution of patients in various modalities of cancer  
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TABLE -  9 :  COMPARISION OF AGE GROUP AND PSYCHIATRIC 
CO-MORBIDITY 
AGE Psychiatric disorder Statistical inference Yes No Total 
a) Below 48yrs 29 50.0% 19 45.2% 48 48.0% X2=.221 
Df=1  
.638>0.05  
Not 
Significant 
b) Above 48yrs 29 50.0% 23 54.8% 52 52.0% 
 <0.05* - significant<0.01**- highly significant 
Table 9:  shows the mean age of 48.2 years and median of 49 years. On 
comparing the two age groups namely below 48 years and above 48 years, who 
were having psychiatric morbidity and not having psychiatric morbidity, the 
p=value is 0.638 which is not statistically significant.  
FIGURE -3:  AGE GROUP AND PSYCHIATRIC CO-MORBIDITY 
 
Figure - 3 shows the Age distrubution of cancer patients with and without 
psychiatric morbidity among the sample population.. 
50.00%
45.20%
48.00%50.00%
54.80%
52.00%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
Yes No Total
Psychiatric disorder
AGE Below 48yrs
AGE Above 48yrs
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TABLE 10 : SEX DISTRUBUTION AND PSYCHIATRIC 
CO-MORBIDITY 
Sex  Psychiatric disorder Statistical inference Yes No Total 
a) Male 17 29.3% 21 50.0% 38 38.0% X2=4.426 Df=1  
.035<0.05  
p=0.035* 
Significant 
b) Female 41 70.7% 21 50.0% 62 62.0% 
<0.05* - significant<0.01**- highly significant 
Table:10 shows, on comparing the sex distrubution and psychiatric morbidity it 
was found that the p value is 0.035 which is statistically significant. 
TABLE – 11:  EDUCATION STATUS AND PSYCHIATRIC 
CO-MORBIDITY 
EDUCATION Psychiatric disorder Statistical inference Yes No Total 
a) Illiterate 32 55.2% 21 50.0% 53 53.0% 
X2=8.707 
Df=4   
.069>0.05 
Not 
Significant 
b) Primary 
School 
23 39.7% 14 33.3% 37 37.0% 
c) High School 2 3.4% 0 .0% 2 2.0% 
d) HSC 1 1.7% 6 14.3% 7 7.0% 
e) Diploma 0 .0% 1 2.4% 1 1.0% 
Total  58 100.0% 42 100.0% 100 100.0% 
<0.05* - significant<0.01**- highly significant 
Table:11 shows no significant association between the education and 
psychiatric morbidity.  
 FIGURE – 4:  EDUCATIONAL LEVEL WITH PSYCHIATRIC 
Figure:4 shows the educational status of the sample population. 55.2% who 
were illiterates had psychiatric disorder.
TABLE – 12:  SOCIO ECONOMIC STATUS AND PSYCHIATRIC 
SOCIO 
ECONOMIC 
STATUS 
Psychiatric disorder
Yes 
a) Lower 11 19.0%
b) Upper 
lower 13 22.4%
c) Lower 
Middle 33 56.9%
d) Upper 
middle 1 1.7%
e) Upper  0 0 
Table: 12  shows there was no significance when comparing socio economic 
status of the population with psychiatric morbidity. 
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
Illiterate
55.20%
50.00%
Psychiatric disorder Yes
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MORBIDITY 
 
CO-MORBIDITY 
 
Total  No  
 6 14.3% 17 17.0% 
 14 33.3% 27 27.0% 
 21 50.0% 54 54.0% 
 1 2.4% 2 2.0% 
0 0 0 0% 
 
 
Primary 
School
High School Hsc Diploma
EDUCATION
39.70%
3.40% 1.70% 0.00%
33.30%
0.00%
14.30%
2.40%
Psychiatric disorder No
 
 
Statistical  
Inference 
X2=1.657 Df=3  
.647>0.05  
Not Significant 
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TABLE:  13- PATIENTS WITH FAMILY HISTORY OF PSYCHIATRIC 
ILLNESS AND PSYCHIATRIC CO-MORBIDITY IN PATIENTS 
FAMILY H/O 
Psychiatric illness 
Psychiatric disorder 
Total  Statistical inference Yes  No  
a) Absent 47 81.0% 40 95.2% 87 87.0% 
X2=4.345 
Df=1 
 .037*<0.05 
Significant b) Present 11 19.0% 2 4.8% 13 
13.0
% 
<0.05* - significant<0.01**- highly significant 
 
Table – 13: shows statistical significance between patients with family history 
of psychiatric illness and cancer patients with psychiatric morbidity. p valve 
0.037 which is statistically significant. 
 
TABLE- 14:  SUBSTANCE USE AND PSYCHIATRIC CO-MORBIDITY 
SUBSTANCE Psychiatric disorder Total  Statistical inference Yes No  
a) No substance 20 34.5% 17 40.5% 37 37.0% X2=.439 
Df=2  
.803>0.05 
Not 
Significant 
b) Tobacco 17 29.3% 12 28.6% 29 29.0% 
c) Alcohol  21 36.2% 13 31.0% 34 34.0% 
 
Table 14: shows the correlation between substane use and psychiatric morbidity 
which not significanct. 
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TABLES- 15: SITE OF MALIGNANCY AND PSYCHIATRIC 
CO-MORBIDITY 
Site Psychiatric disorder 
Without 
psychiatric 
disorder  
Total 
Head and Neck Cancer 16 27.6% 16 38.1% 32 32.0% 
Thorax 14 24.1% 9 21.4% 23 23.0% 
GIT 11 19.0% 2 4.8% 13 13.0% 
Genito -Urinary System 15 25.9% 11 26.2% 26 26.0% 
Haematological 
Malignancy 1 1.7% 2 4.8% 3 3.0% 
Skin 1 1.7% 2 4.8% 3 3.0% 
Total 58 100.0% 42 100.0% 100 100.0% 
 
Table 15: shows the frequency of association between the site of cancer and  
psychiatric morbidity. Among 32 patients with head and neck cancer, 16 
patients had psychiatric disorder. Out of 23 patients with thoracic cancer, 14 had 
psychiatric disorder. Out of 13 patients with GIT cancer, 11 patients had 
psychiatric disorder. Comparing the hematological maligancy out of 3 patients, 
1 patient had psychiatric disorder and  2 patients were not found to have any 
psychiatric disorder. 
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FIGURE 5  : SITE OF MALIGANCY AND PSYCHIATRIC 
CO-MORBIDITY
 
Figure 5: shows the prevalence of psychiatric morbidity in relation to the site of 
maligancy. Head and Neck cancer 27.6% had psychiatric disorder, Thoracic 
cancer 24.1% had psychiatric disorder, GIT cancer 19.0% had psychiatric 
morbidity, Genito urinary cancer 25.9% had psychiatric disorder, 
Heamatological and skin cancer 1.7% had psychiatric disorder. 
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TABLE – 16: STAGE OF CANCER AND PSYCHIATRIC  
CO-MORBIDITY 
STAGE 
Psychiatric disorder 
Total Statistical inference Yes No 
a) Early 
Carcinoma 26 44.8% 20 47.6% 46 46.0% 
X2=.076 Df=1  
.782>0.05  
Not Significant 
b) Advanced  
Carcinoma 32 55.2% 22 52.4% 54 54.0% 
 
Table 16: shows the prevalance of psychaitric morbidity among the early stage 
of cancer (44.80%)  and advance stage (55.2%) as compared to patients without 
the psychiatric disorder 47.60% in early and 52.40% in advanced cancers.  The 
results were not found to be statistically significant. 
TABLE – 17 : MODE OF TREATMENT WITH PSYCHIATRIC  
CO-MORBIDITY 
MODE OF 
TREATMENT 
Psychiatric disorder 
Total  Statistical inference  Yes No 
Radiotherapy 23 39.7% 16 38.1% 39 39.0% X2=1.344 Df=2  
.511>0.05  
Not Significant 
Chemotherapy 15 25.9% 15 35.7% 30 30.0% 
Surgery 20 34.5% 11 26.2% 31 31.0% 
<0.05* - significant<0.01**- highly significant. 
Table 17: shows no significance between the mode of treatment and psychaitric 
morbidity. 
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TABLE  18: PSYCHIATRIC MORBIDITY WITH TREATMENT 
VARIABLE 
PSYCHIATRIC  
DISORDER 
RT CT ST TOTAL STATISTICAL INFERENCE 
Depression 6 15.4% 3 10.0% 7 22.6% 16 16.0% 
X2=12.709 
Df=12 
.391>0.05  
Not 
Significant 
Dysthymia 0 .0% 2 6.7% 1 3.2% 3 3.0% 
Panic disorder 0 .0% 1 3.3% 3 9.7% 4 4.0% 
PTSD 0 .0% 1 3.3% 1 3.2% 2 2.0% 
GAD 3 7.7% 1 3.3% 2 6.5% 6 6.0% 
Adjustment 
disorder 14 35.9% 7 23.3% 6 19.4% 27 27.0% 
NAD 16 41.0% 15 50.0% 11 35.5% 42 42.0% 
 
Table 18 :  prevalence of psychiatric morbidity among the patients who 
receiving the Radiotherapy, chemotherapy and surgery. Among the 39 Patients 
who receiving the radiotherapy treatment, 6 had depression, 3 had GAD, 14 
patients had Adjustment disorder.  30 patients on chemotherapy treatment, 3 
had depression , 2 had Dysthymia , 1 panic disorder,1 had PTSD, 1 had GAD 
and 7 patients had Adjustment disorder.  Among 31 patients on surgical 
treatment, 7 had depression, 1 had Dysthymia, 3 had panic disorder,1 had 
PTSD,2 had GAD and 6 patients had Adjustment disorder.   The results found 
no significance.  
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TABLE 19: DURATION OF RT/CT/ST AND PSYCHIATRIC  
CO-MORBIDITY 
DURATION OF 
TREAMENT 
Psychiatric disorder 
Total  Statistical inference Yes No 
Below 3weeks 12 20.7% 16 38.1% 28 28.0% X2=3.661 Df=1  
.056>0.05  
Not Significant 
Above 3weeks 46 79.3% 26 61.9% 72 72.0% 
<0.05* - significant<0.01**- highly significant. 
Table 19: show duration of treatment and psychiatric morbidity found no 
significance. 
TABLE 20: DURATION OF TREATMENT OF RADIOTHERAPY AND 
PSYCHIATRIC CO-MORBIDITY 
Duration of 
Radiotherapy  
Psychiatric disorder Normal Total 
N=39 
Statistical 
inference 
Below 3 
weeks 
7 30.4% 11 68.8% 18 46.2% X2=5.574 
Df=1  
.018<0.05 
Significant Above 3 
weeks 
16 69.6% 5 31.3% 21 53.8% 
Total 2 100.0% 16 100.0% 39 100.0% 
<0.05* - significant<0.01**- highly significant. 
Table 22: shows Duration of  Radiotherapy Treatment and psychiatric 
morbidity. The p value is 0.018 which is statistically significant. 
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TABLE 21: DURATION OF TREATMENT OF CHEMOTHERAPY  
AND PSYCHIATRIC CO-MORBIDITY 
DURATION 
OF 
TREAMENT 
MINI PLUS Statistical 
inference 
Psychiatric 
disorder 
Normal 
Total 
N=30 
 
      
Below 
3weeks 2 
13.3% 4 26.7% 6 20.0% X
2
=.833 
Df=1 
.361>0.05 
Not 
Significant 
Above 
3weeks 13 
86.7% 11 73.3% 24 80.0% 
Total 15 100.0% 15 100.0% 30 100.0%  
 
Table 21 : shows duration of Chemotherapy treatment and psychiatric             
co-morbidity, among the 30 patients received CT 13 patients had psychiatric   
co-morbidity belong to more than 3 weeks of duration, 2 patients have 
psychiatric co-morbidity below 3 weeks which is statistically not significant.  
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TABLE 22: DURATION OF TREATMENT OF SURGERY AND 
PSYCHIATRIC CO-MORBIDITY 
DURATION OF 
TRREAMENT 
MINI PLUS 
Statistical 
inference Psychiatric 
disorder Normal 
Total 
N=31 
Below 3weeks 3 15.0% 1 9.1% 4 12.9% X2=.220 
Df=1  
.639>0.05 
 Not 
Significant 
Above 3weeks 17 85.0% 10 90.9% 27 87.1% 
Total 20 100.0% 11 100.0% 31 100.0%  
Table : 22 shows the duration of surgical treatment and psychiatric co-
morbidity, among the 31 patients undergone surgical treatment, 17 had 
psychiatric co-morbidity above 3 weeks and 3 had psychiatric co-morbidity 
below 3 weeks.  This is statistically not significant. 
TABLE 23: NUMBER OF TREATMENT OF CT/RT/SURGERY AND 
PSYCHIATRIC MORBIDITY 
NO. CT/RT 
Psychiatric disorder 
Total  Statistical inference 
Yes No 
Below 3 numbers 26 44.8% 21 50.0% 47 47.0% X2=3.616 Df=2  
.164>0.05  
Not Significant 
Above 3 numbers 32 55.2% 21 50.0% 53 53.0% 
Table 23: shows number of chemotherapy, radiotherapy and psychiatric 
morbidity found no significance. 
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TABLE 24: DURATION FROM LAST TREATMENT AND 
PSYCHIATRIC MORBIDITY 
DURATION LAST 
Treatment  
Psychiatric disorder 
Total Statistical inference Yes No 
Below 7 weeks 20 34.5% 25 59.5% 45 45.0% X2=6.172 Df=1  
.013<0.05 
Significant Above 7 weeks 38 65.5% 17 40.5% 55 55.0% 
<0.05* - significant<0.01**- highly significant. 
Table 24: shows the duration from last treatment and psychiatric morbidity p 
value found statistically significant. (p = 0.013). 
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DISCUSSION 
 
          The aim of the study is to evaluate the psychiatric co-morbidity among 
the cancer patients attending the oncology clinic in tertiary care South Indian 
Hospital, and to assess the type of psychiatric co-morbidity among the various 
cancer patients. 
As the concept of ‘General Hospital Psychiatry’ or better to say 
‘consultation liaison psychiatry’ is gaining around in the field, more and more 
researches focusing on psychiatric aspects of medical diseases are coming forth.  
This study was taken to contribute to the growing body of literature in 
psycho-oncology worldwide, as data in this respect is limited for Indian 
population.  
 The present study is a cross sectional descriptive study; consecutive 
sampling methods were used to recruit the subjects, those who were attending 
the OP and IP of Oncology Department, South Indian Tertiary Care Hospital for 
treatment. The sample size consisted of 100 patients. Recruitment was 
accomplished by using inclusion and exclusion criteria and consent was 
obtained for participation in the study from each and every patient.   
All subjects were evaluated using socio-demographic proforma, 
Kuppuswamy rating scale for socioeconomic scale, General Health 
Questionnaire-12 (GHQ-12) for screening psychiatric disorder in the medical 
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out-patient population, MINI International Neuropsychiatric Interview for 
assessing psychiatric co-morbidity, Hamilton Rating Scale(HAM-D and HAM-
A) for assessing the severity of Anxiety and Depression. The order of 
presentation of instruments was kept identical for all subjects. The patients’ 
Socio-demographic profile, Site of Cancer, Stage of Cancer, Duration of 
treatment, Treatment variables- Chemotherapy group, Radiotherapy group and 
Surgical group were compared and analysed. 
Socio-demographic profile of cancer patients. 
A total of 100 patients diagnosed with malignancy were evaluated for the 
study. Among them, majority of patients belonged to the age group of 36 – 50 
years  (46.0 % ) , 34.0% of patients belonged to 50 – 65 years and remaining 
20.0%  belonged to 18 – 35 years.  This study had patients’ age ranging from 30 
to 65 years, with the mean age of 48.29 years and median age of 49 years. 
In this study the sample population consisted more of female patients 
(62.0%), as compared with the male patients 32.0% (Male Vs Female ratio of 
1:1.6). 
Among the 100 cancer patients, 88.0% of them were from rural area and 
remaining 12.0% were from urban area.  
Considering theeducational level of patients, 53% patients were illiterate 
and 37% of them studied upto primary school , 2.0% studied upto high schools 
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and 7.0% completed their higher secondary education, and only one completed 
degree.   
Regarding the occupational status, 65.0% were unemployed, 17.0% were 
employed in semiskilled job, 13.0% under unskilled and remaining 5.0% skilled 
workers.   
Among the study groups, 54.0% belonged to lower middle, 2.0% from 
upper middle, 27.0% from upper lower and 17.0% from the lower socio 
economic status.   
Majority of the patients were married(98.0%) and only 2.0%  unmarried.  
Most of them (87.0%) belong to the nuclear family and about 13.0% 
belonged to joint family.   
Among the cancer group, 29.0% had history of using tobacco alone in the 
form of chewing and smoking, whereas 34.0% had history of using both alcohol 
and tobacco,the remaining37.0% were not exposed to any kind of substance.   
In this study among 100 cancer patients, only 13 patients had family 
history of psychiatric disorder.  
Considering the medical co-morbidity like Hypertension and Diabetes 
mellitus among the sample population, only 16 patients out of 100  had history 
of Hypertension and Diabetes Mellitus.   
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Socio demographic profile and psychiatric co-morbidity in study sample 
In this study we consider the mean age to be 48 years. On comparing the 
median age of 48 years, both the groups are equally distributed among the 
psychiatric co-morbidity (50%). A Meta Analysis of 58 studies after 1980, 
showed that studies with younger patients(2) reported significantly more 
depression, anxiety and general distress than studies with older patients with 
mean age 50 years or over.  
 On comparing the sex distribution of the patients, 38% were males and 
62% were females with a male female ratio of 1:1.6. Among the 38 male 
patients, 17 patients had psychiatric co-morbidity and remaining 21 patients 
were without psychiatric disorder. Among the 62 female patients, 41 patients 
had psychiatric co-morbidity and 21 patients were without psychiatric disorder. 
p value =0.035 was statistically significant. Results on comparing found that 
psychiatric co-morbidity is significantly high among the female cancer patients.  
A study from Kerala by Pandey et al.103 also showed the similar results as 
compared with this study.   
 Comparing the Educational status, among the 58 cancer patients having 
psychiatric disorder, majority of them wereilliterates(55.0%),39.7% studied 
upto primary school, 3.4%  upto high schol and 1.7 % completed upto higher 
secondary school.  In an Indian study conducted by Mendonsa et al, 2010, 
psychiatric co-morbidity was found to be high among illiterate population, those 
82 
 
from lower economic group, rural population and in house-wives. It is argued 
that people of low social class are unaware of the high risk behaviour that 
initiates cancer. There is also a reduced knowledge on the early signs of cancer 
and therby the treatment seeking is also delayed.104 
 Comparing the distribution of patients with psychiatric co-morbidity in 
terms of type of family, out of 58 patients, 49 patients (84.5%) belong to 
nuclear family, 9 patients (15.5%) belong to joint family. In a study conducted 
by Mishra et al32, 73% of the patients belong to nuclear family.105 
 Comparing the distribution of patients with psychiatric co-morbidity in 
terms of socio economic status, out of 58 patients, 11 patients (19%) belonged 
to lower class, 13 patients (22.4%) belonged to upper lower class, 33 patients 
(56.9%) belonged to lower middle class and 1 patient (1.7%) were in upper 
middle class. In studies conducted by Agarwal et al, 1990, and Laura E 
Simonelli et al, 2008, these results argue that psychiatric co-morbidity is 
common in rural population, and in low socio economic group.106,107  
 Comparing the distribution of patients with psychiatric co-morbidity in 
terms of family history of psychiatric illness, out of 58 patients, 11 patients 
(19%) had positive family history and the remaining 47 patients (81%) were 
without positive family history.  Report shows that the family history of 
psychiatric illness is a predictor of depression in the patients (Kaplan and 
Saddock, 2009)25 
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Site of cancer among  sample population. 
In this study among the 100 patients, 32% had Head and neck cancer 
which include the upper Aerodigestive system ( tongue, cheek, lip, nasal, larynx 
and pharyneal carcinoma), 23% had Thoracic cancer which include  breast and 
lung, 13% had GIT cancer which include pancreas, liver, stomach, colon, small 
intestine,  26% had Genito urinary cancer ( bladder, cervix,ovary,testicular), 3% 
had Hematological maligancy consisting of lymphoma and leukemia, and 3% 
had Skin cancer (malignant melanoma). In the reference from WHO 2003, 
world cancer report, Ed.By Bernald W.Stewart and Paul Kleihues., the global 
burden of cancer incidence and mortality is shown in terms of incidence, the 
most common cancer worldwide is lung cancer 12.3% and breast cancer is 
10.4% and colorectal cancer is 9.4%.34 
Site of cancer among sample population and psychiatric co-morbidity: 
In this study among the 100 cancer patients, 58% of the study population 
were found to be having psychiatric co-morbidity. 
 In this study, among 100 cancer patients, comparing withthe site of 
cancer andpsychiatric co-morbidity, among 32 patients with head and neck 
cancer, 16 (27.6%)of them had psychiatric co-morbidity and the remaining16 
patients were without psychiatric illness.  Amongthe 23 Thoracic cancer 
patients,14 (24.1%) of them had psychiatric illness and  9 patients were without 
psychiatric disorder.   Among the 13 patients with GIT cancer, 11(19.0%) 
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patients had psychiatric co-morbidity and 2 patients were without psychiatric 
disorder. In genito urinary cancers,out 26 patients, 15(25.9%)patients were 
found to have psychiatric co-morbidity and 11 patients were without psychiatric 
disorder.  In Heamotological maligancy,  1 (1.7%)patient had psychiatric co-
morbidity and  2 patients were without psychiatric disorder. Among the 3 skin 
cancer patients, 1 (1.7%)patient had psychiatric co-morbidity and 2 patients 
were without psychiatric co-morbidity.The results found that no significant 
association  were identified between the site of maligancy and psychiatric co-
morbidity, which is in concordance with the study conducted by Gagan Hane, 
Mohammed M.Dar, et al, 2015.108 
Stage of cancer among sample population and psychiatric co-morbidity: 
 Comparing the distribution of patients with psychiatric co-morbidity 
with stage of cancer, out of 58 patients, 26 patients (44.8%) were in early 
carcinoma stage and the remaining 32 patients (55.2%) were in the advance 
carcinoma stage. In a study conducted by Toshiko matsushitha et al, 2007, 
argues that the anger-hostility score was found to be lowerst in the patients in 
advance stage of illness and the highest in those with benign illness.109 
PREVALENCE OF PSYCHIATRIC CO-MORBIDITIES IN CANCER PATIENTS 
The psychiatric co-morbidity in the cancer patients is often under-
diagnosed. Data regarding the prevalence of psychiatric disorders in cancer 
patients is sparse.  
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 In this study among the 100 cancer patients, 58% of the study population 
were found to be having psychiatric co-morbidity. This high prevalence of 
psychiatric disorder is comparable with that of study done by Derogatis et al(5)in 
which47% of the study population had psychiatric co-morbidity.  This result 
which is lower than this study, shows that psychiatric co-morbidity is high 
among the Indian population.  
 In Indian study conducted by Chaturvedi et al(41) had found that 38% of 
cancer patients had identifiable DSM-III anxiety or depressive disorders. This 
result is also lower than this study results, stressing the high prevalence in South 
Indian population. 
Another National study by Alexander et.al.(30)has found psychiatric co-
morbidity  in 40 % of the study population, which again is also lower than this 
study having 58% psychiatric co-morbidity. 
 Another study by Ashraff et al. at the malignant disease treatment centre, 
AFMC Pune found out that 44% of patients had a psychiatric diagnosis which  
is also lower than this study.  
          In the study conducted by Mishra et al(105), 63% of patients were found to 
have psychiatric co-morbidity, which is higher than this study results. These 
points are towards the fact that the prevalence of psychiatric co-morbidity in 
South Indian population is high. 
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In this study the prevalence of Adjustment disorder is 46.6%.  In a study 
done by Derogatis et al5, prevalence of Adjustment disorders is 68%.  This 
results were low compared with the above study signifies the prevalence of 
adjustment disorder is low among South Indian population. In a study in Indian 
population conducted by Gopalan MR et al. conclude that 41.7% had 
psychiatric disorders. Adjustment disorders were seen in 22.6%, 10.9% of 
subjects had major depressive disorder. Total of 33.5% of patients had diagnosis 
of Anxiety or depression. Adjustment disorder is most common psychiatric 
morbidity among the cancer patients. 
The diagnosis of cancer may precipitate adjustment disorders which may 
be associated with depressed mood, anxious mood, and mixed emotional 
features. Diagnosis of cancer may lead to a normal stress reaction. But these 
patients use their normal coping mechanisms to tackle these stresses and 
continue living without functional impairment. Patients with poor coping skills 
land up with adjustment disorder.  
Prevalence of Depressive Disorders: 
In this study out of 58 patients with psychiatric co-morbidity, prevalence 
of depressive disorders were 27.6 %.  When compared with the study done by 
Alexander et al.103 with total prevalence of depressive disorders to be 32%, the 
prevalence of depressive disorders in this study population is low. 
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In another study, conducted by the Massie et al. reported that prevalence 
of major depression varied from 0% to 38% which was explained by the 
associative factors as varying in the conceptualization of major and minor 
depression, different criteria were used to define depression, difference in 
methodological approach to assess the depression and different population 
studied.  Another study has noted that depression range from 12 to 30% in 
general medical and primary practice populations.  Comparing with all the 
above study results, the prevalence of depression in this study is similar. 
Prevalence of Anxiety Disorders: 
In this study, 20.6% had Anxiety disorders among the cancer patients, 
(6.9% had Panic disorder, 10.3% had Generalised Anxiety disorder and 3.4% 
had PTSD). The study conducted by Craig et al (1974) among the 
haematological cancer patients found to have 30% of anxiety disorders. This 
result is high compared to this study, which signifies the low prevalence of 
anxiety disorders among the sample population. 
Prevalence of Depression and Anxiety Disorders: 
In various studies, depression and anxiety disorders together accounted 
over 90% of all psychiatric diagnoses68. In this study depression (27.6%) and 
anxiety disorders (20.6%) together accounted to 48.2% and adjustment 
disorders of about 46.6%, with a total of 94.8% are in keeping with the 
observation of Derogatis et al. and Alexander et al. that depressive and anxiety 
disorders comprise the majority of psychiatric diagnoses in cancer patients. 
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Treatment variables and psychiatric co-morbidity: 
Chemotherapy: 
 In this study out of 30 patients undergoing Chemotherapy,  
16.7%patients (depression 10.0% and dysthymia 6.7%) had depressive disorder, 
9.9% patients (Panic disorder 3.3%, PTSD 3.3%, GAD 3.3%) had anxiety 
disorder and 23.3% patients had adjustment disorder.   
 In the study from kerala by Pandey et al106 , it was shown that among the 
patients undergoing chemotherapy, 16.23% had depression and 15.38% had 
anxiety disorder.    The history of chemotherapy has been shown to be 
associated with psychiatric problems.    This study result is similiar to the 
depression and  low prevalence in anxiety disorder, and high prevalence of 
adjustment disorder. This points towards the fact that the prevalence of 
psychiatric co-morbidity is high in chemotherapy population in South Indian 
Population. 
Surgery: 
In this study, among 31patients who had undergone surgical treatment, 25.8% 
(depression 22.6%, dysthymia 3.2%) of had depressive disorders, 19.4% (panic 
disorder 9.7%, PTSD 3.2%, GAD 6.5%) had anxiety disorder and 19.4% had 
Adjustment disorder.   
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 In a study conducted by morris et al. found 22% prevalence of 
depression in who had undergone mastectomy for breast cancer and Maguire 
et.al.81  found 26% moderate or severe depression among women who had 
undergone mastectomy compared with a 12% of prevalence of depression in 
women with benign disease.   The prevalence of depression in this study is 
similar to the above mentioned studies. 
Radiotherapy:  
 In this study, among the 39 patients who had undergone Radiotherapy,  
15.4% had depression, 7.7% had anxiety disorder and 35.9% had adjustment 
disorder. In the study done by Schmale et al55 have shown significant 
psychiatric problems associated with radiotherapy. 
Duration of treatment in Radiotherapy and psychiatric co-morbidity: 
 In this study patient with psychiatric co-morbidity in Radiotherapy 
patient compare with duration of treatment , below 3 weeks had 30.4% had 
psychiatric co-morbidity, 69.6%  above 3 weeks of RT had psychiatric co-
morbidity. This result was found to be significant (p=0.018).  This result shows 
high prevalence of psychiatric co-morbidity, in patients had more duration of 
Radiotherapy treatment.  
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CONCLUSION 
 
The study findings reveal, with respect to the Hypothesis that  
1. Psychiatric co-morbidity is highly prevalent in patient with cancer 
patients. 
2. Adjustment disorder and depression are the most common Psychiatric co-
morbidity associated with Cancer patients. 
3. There is significantly high prevalence of psychiatric co-morbidity among 
the female cancer patients.  
4. There is high prevalence of psychiatric morbidity among the patients with 
the positive family history of psychiatric illness. 
5. No difference with respect to age, Socioeconomic class is seen in terms 
of co-morbid psychiatric disorders. 
6. There is no risk of developing a co-morbid psychiatric illness with stage 
of cancer. 
7. There is no difference with respect to Duration of Illness, in the 
presentation of psychiatric co morbidity. 
8. There is significant prevalence of psychiatric morbidity, among the 
patients with duration of last treatment. 
9. There is high prevalence of psychiatric morbidity among the patient 
receiving Radio therapy than CT/ST. 
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LIMITATIONS OF THE STUDY 
1. This study is a cross sectional descriptive study, hence the longitudinal 
course and outcome of the patients could not be assessed. 
2. Socio – demographic matching was difficult in this study as limited 
number of cancer admissions in our Hospital during study time period. 
This result can’t be generalised. 
3. The study sample is small. Further studies on a larger sample are needed. 
4. A hospital based method of sampling, only on those patients who were 
admitted in hospital for evaluation. Hence the results cannot be 
generalized to all people diagnosed as having cancer. 
5. Duration of diagnosis of the illness to assessment time was not included. 
This will be reflected in the result.  
Future direction: 
Different types of treatment in cancer patient and psychiatric morbidities 
would help us in comprehensive understanding of psycho-oncology. More 
prospective studies are needed to study the association of psychiatric 
morbidities and cancer patients as these would be more accurate in diagnosing 
the psychiatric condition. 
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ANNEXURE I   
SEMISTRUCTURED PROFORMA 
PROFORMA 
NAME:                                                        OP/IP NO:                                         
AGE:                                                            INFORMANT:                                   
ADDRESS:                                                 PHONE NUMBER: 
EDUCATIONAL STATUS:  Profession/Graduate or post 
graduate/Intermediate or post high school diploma/High school/ Middle 
school/Primary school/Illiterate       
OCCUPATION: Profession/Semi-Profession/Clerical, Shop-owner, 
Farmer/Skilled worker/Semi-skilled worker/Unskilled worker/Unemployed                             
INCOME:                                                         
MARITAL STATUS:              TYPE OF FAMILY: nuclear/joint/extended 
Number of family members:  
PRESENTING COMPLAINTS :( carcinoma) 
Duration :                                                   Time of consultation:                                                                      
Diagnosis  :                                                                                          
Site of lesion :                                       
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Mode of treatment: CT/RT/ST 
Number of CT/RT/ST :  
Duration of last treatment: <7 weeks / >7weeks 
PRESENTING COMPLAINTS: (PSYCHIATRIC) 
Duration:                                                               H/O Treatment                                                                                                             
PAST HISTORY:                                                                                                 
Psychiatric illness:                   Suicidal attempt:               Stressors:                                            
Medical/surgical illness:          others:                                                                                             
FAMILY HISTORY:                                                                                                        
Type of family:                                     H/O psychiatric illness:                                           
No of family members:                         H/O suicidal attempts:                                           
Earning members:                                 H/O missing persons/MR:                                            
Total income: 
PERSONAL HISTORY:                                                                                                  
AN/PN history:                             Developmental milestones:                                                         
Academic performance:                Occupational history:                 
Substance /Drug intake  History:   1. Alcohol        2. Tobacco.                                                         
PREMORBID PERSONALITY: 
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GENERAL EXAMINATION:                                                                                              
B.P:              mm. Hg      P.R:  /Min                                                                      
Self-Inflicted Wounds:                                                                                                        
C.V.S:                                                                                                                                 
R.S:                                                                                                                             
ABDOMEN:                                                                                                                      
C.N.S:                                                                      
MENTAL STATUS EXAMINATION:                                                                                                   
General appearance/co-operation:                                                                                 
Psychomotor activity:                                                                                                       
Talk:                                                                                                                 
Thought:                                                                                                     
Perception:                                                                                                                                    
Mood   
DIAGNOSIS: 
LAB INVESTIGATIONS: 
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ANNEXURE II 
KUPPUSAMY’S SOCIO ECONOMIC SCALE: 
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ANNEXURE - III 
 
GENERAL HEALTH QUESTIONNAIRE 
 
Name…………………………………………………. 
We want to know how your health has been in general over the last few weeks. 
Please read the questions below and each of the four possible answers. Circle 
the response that best applies to you. Thank you for answering all the questions. 
Have you recently: 
1. been able to concentrate on what you’re doing? 
(0) better than usual (1) same as usual (2) less than usual (3)much less than 
usual. 
2. lost much sleep over worry? 
(0) Not at all (1) no more than usual (2)rather more than usual (3) much more 
than usual. 
3. felt that you are playing a useful part in things? 
(1) more so than usual (1)same as usual (2) less so than usual (3) much less than 
usual. 
4. felt capable of making decisions about things? 
(0) more so than usual (1) same as usual (2) less than usual (3)much less than 
usual. 
5. felt constantly under strain? 
(0) Not at all (1) no more than usual (2) rather more than usual (3)much more 
than usual. 
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6. felt you couldn’t overcome your difficulties? 
(0) Not at all (1) no more than usual (2) rather more than usual (3)much more 
than usual. 
7. been able to enjoy your normal day to day activities? 
(0) more so than usual (1) same as usual (2) less than usual (3)much less than 
usual. 
8. been able to face up to your problems? 
(0) more so than usual (1) same as usual (2) less than usual (3)much less than 
usual. 
9. been feeling unhappy or depressed? 
(0) Not at all (1) no more than usual (2) rather more than usual (3)much more 
than usual. 
10. been losing confidence in yourself? 
(0) Not at all (1) no more than usual (2) rather more than usual (3)much more 
than usual. 
11. been thinking of yourself as a worthless person? 
(0) Not at all (1) no more than usual (2) rather more than usual (3)much more 
than usual. 
12. been feeling reasonably happy, all things considered? 
(0) more so than usual (1) same as usual (2) less than usual (3)much less than 
usual. 
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ANNEXURE IV 
MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW 
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ANNEXURE – III 
HAMILTON DEPRESSION RATING SCALE (HDRS) 
Instructions: for each item select the one “cue” which best characterizes the 
patient. Be sure to record the answers in the appropriate spaces (score 0  to  4). 
1 DEPRESSED MOOD (sadness, hopeless, helpless, worthless) 
0 |__| Absent. 
1 |__| These feeling states indicated only on questioning. 
2 |__| These feeling states spontaneously reported verbally. 
3 |__| Communicates feeling states non-verbally, i.e. through facial expression, 
posture, voice and tendency to weep. 
4 |__| Patient reports virtually only these feeling states in his/her spontaneous 
verbal and non-verbal communication. 
2 FEELINGS OF GUILT 
0 |__| Absent. 
1 |__| Self reproach, feels he/she has let people down. 
2 |__| Ideas of guilt or rumination over past errors or sinful deeds. 
3 |__| Present illness is a punishment. Delusions of guilt. 
4 |__| Hears accusatory or denunciatory voices and/or experiences threatening 
visual 
hallucinations. 
 
111 
 
3 SUICIDE 
0 |__| Absent. 
1 |__| Feels life is not worth living. 
2 |__| Wishes he/she were dead or any thoughts of possible death to self. 
3 |__| Ideas or gestures of suicide. 
4 |__| Attempts at suicide (any serious attempt rate 4) 
4 INSOMNIA: EARLY IN THE NIGHT 
0 |__| No difficulty falling asleep. 
1 |__| Complains of occasional difficulty falling asleep, i.e.more than 1⁄2 hour. 
2 |__| Complains of nightly difficulty falling asleep. 
5 INSOMNIA: MIDDLE OF THE NIGHT 
0 |__| No difficulty. 
1 |__| Patient complains of being restless and disturbed during the night. 
2 |__| Waking during the night – any getting out of bed rates 2 (except for 
purposes of voiding). 
6 INSOMNIA: EARLY HOURS OF THE MORNING 
0 |__| No difficulty. 
1 |__| Waking in early hours of the morning but goes back to sleep. 
2 |__| Unable to fall asleep again if he/she gets out of bed. 
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7 WORK AND ACTIVITIES 
0 |__| No difficulty. 
1 |__| Thoughts and feelings of incapacity, fatigue or weakness related to 
activities, work or hobbies. 
2 |__| Loss of interest in activity, hobbies or work – either directly reported by 
the patient or indirect in listlessness, indecision and vacillation (feels he/she has 
to push self to work or activities). 
3 |__| Decrease in actual time spent in activities or decrease in productivity. 
Rate 3 if the patient does not spend at least three hours a day in activities (job or 
hobbies) excluding routine chores. 
4 |__| Stopped working because of present illness. Rate 4 if patient engages in 
no activities except routine chores, or if patient fails to perform routine chores 
unassisted. 
8 RETARDATION (slowness of thought and speech, impaired ability to 
concentrate, decreased motor activity) 
0 |__| Normal speech and thought. 
1 |__| Slight retardation during the interview. 
2 |__| Obvious retardation during the interview. 
3 |__| Interview difficult. 
4 |__| Complete stupor. 
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9 AGITATION 
0 |__| None. 
1 |__| Fidgetiness. 
2 |__| Playing with hands, hair, etc. 
3 |__| Moving about, can’t sit still. 
4 |__| Hand wringing, nail biting, hair-pulling, biting of lips. 
10 ANXIETY PSYCHIC 
0 |__| No difficulty. 
1 |__| Subjective tension and irritability. 
2 |__| Worrying about minor matters. 
3 |__| Apprehensive attitude apparent in face or speech. 
4 |__| Fears expressed without questioning. 
11 ANXIETY SOMATIC (physiological concomitants of anxiety) such as: 
gastro-intestinal – dry mouth, wind, indigestion, diarrhea, cramps, belching 
cardio-vascular – palpitations, headaches respiratory – hyperventilation, sighing 
urinary frequency sweating 
0 |__| Absent. 
1 |__| Mild. 
2 |__| Moderate. 
3 |__| Severe. 
4 |__| Incapacitating. 
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12 SOMATIC SYMPTOMS GASTRO-INTESTINAL 
0 |__| None. 
1 |__| Loss of appetite but eating without staff encouragement. Heavy feelings 
in abdomen. 
2 |__| Difficulty eating without staff urging. Requests or requires laxatives or 
medication for bowels or medication for gastro-intestinal symptoms. 
13 GENERAL SOMATIC SYMPTOMS 
0 |__| None. 
1 |__| Heaviness in limbs, back or head. Backaches, headaches, muscle aches. 
Loss of energy and fatigability. 
2 |__| Any clear-cut symptom rates 2. 
14 GENITAL SYMPTOMS (symptoms such as loss of libido, menstrual 
disturbances) 
0 |__| Absent. 
1 |__| Mild. 
2 |__| Severe. 
15 HYPOCHONDRIASIS 
0 |__| Not present. 
1 |__| Self-absorption (bodily). 
2 |__| Preoccupation with health. 
3 |__| Frequent complaints, requests for help, etc. 
4 |__| Hypochondriacal delusions. 
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16 LOSS OF WEIGHT (RATE EITHER a OR b) 
a) According to the b) According to weekly patient: measurements: 
0 |__| No weight loss. 0 |__| Less than 1 lb weight loss in week. 
1 |__| Probable weight 1 |__| Greater than 1 lb weight loss loss associated with 
in week. present illness. 
2 |__| Definite (according 2 |__| Greater than 2 lb weight loss to patient) weight 
in week. loss. 
3 |__| Not assessed. 3 |__| Not assessed. 
17 INSIGHT 
0 |__| Acknowledges being depressed and ill. 
1 |__| Acknowledges illness but attributes cause to bad food, climate, overwork, 
virus, need for rest, etc. 
2 |__| Denies being ill at all. 
Total score: |__|__| 
SCORING: <7 normal, 8-13 mild, 14-18 moderate, 19-22 severe, >23 very 
severe. 
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ANNEXURE VI 
HAMILTON ANXIETY RATING SCALE (HAM-A) 
Below is a list of phrases that describe certain feeling that people have. Rate the 
patients by finding the answer which best describes the extent to which he/she 
has these conditions. Select one of the five responses for each of the fourteen 
questions. 0 = Not present, 1 =Mild, 2= Moderate, 3 =Severe, 4= Very severe. 
1 Anxious mood - 0 1 2 3 4 
Worries, anticipation of the worst, fearful anticipation, irritability. 
2 Tension -  0 1 2 3 4 
Feelings of tension, fatigability, startle response, moved to tears easily, 
trembling, feelings of restlessness, inability to relax. 
3 Fears - 0 1 2 3 4 
Of dark, of strangers, of being left alone, of animals, of traffic, of crowds. 
4 Insomnia 0 1 2 3 4 
Difficulty in falling asleep, broken sleep, unsatisfying sleep and fatigue 
on waking, dreams, nightmares, night terrors. 
5 Intellectual 0 1 2 3 4 
Difficulty in concentration, poor memory. 
6 Depressed mood 0 1 2 3 4 
Loss of interest, lack of pleasure in hobbies, depression, early waking, diurnal 
swing. 
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7 Somatic (muscular) 0 1 2 3 4 
Pains and aches, twitching, stiffness, myoclonic jerks, grinding of teeth, 
unsteady voice, increased muscular tone. 
8 Somatic (sensory) 0 1 2 3 4 
Tinnitus, blurring of vision, hot and cold flushes, feelings of weakness, pricking 
sensation. 
9 Cardiovascular symptoms 0 1 2 3 4 
Tachycardia, palpitations, pain in chest, throbbing of vessels, fainting feelings, 
missing beat. 
10 Respiratory symptoms 0 1 2 3 4 
Pressure or constriction in chest, choking feelings, sighing, dyspnea.  
11 Gastrointestinal symptoms 0 1 2 3 4 
Difficulty in swallowing, wind abdominal pain, burning sensations, abdominal 
fullness, nausea, vomiting, borborygmi, looseness of bowels, loss of weight, 
constipation. 
12 Genitourinary symptoms 0 1 2 3 4 
Frequency of micturition, urgency of micturition, amenorrhea, menorrhagia, 
development of frigidity, premature ejaculation, loss of libido, impotence. 
13 Autonomic symptoms 0 1 2 3 4 
Dry mouth, flushing, pallor, tendency to sweat, giddiness, tension headache, 
raising of hair. 
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14 Behavior at interview 0 1 2 3 4 
Fidgeting, restlessness or pacing, tremor of hands, furrowed brow, strained face, 
sighing or rapid respiration, facial pallor, swallowing, etc. 
Scoring: <17 mild, 18-24 mild to moderate, 25-30 moderate to severe. 
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KEY TO MASTER CHART 
AGE 1 : 18 TO 35 
2 : 36 – 50 
3 : 51 – 65  
RELIGION 1 : HINDU 
2 : CHIRISITIAN 
3 : MUSLIM 
MARITAL STATUS 1 : UNMARRIED 
2 : MARRIED 
3 : WIDOW 
4 : DIVORCEEING 
EDUCATIONAL QUALIFICATION 1 : ILLITEARATE 
2 : PRIMARY SCHOOL 
3 : HIGH SCHOOL 
4 : HIGHER SECONDARY 
5: DIPLOMA 
OCCUPATION 1 : SKILLED 
2 : SEMI SKILLED 
3 : UNSKILLED 
4 : UN EMPLOYED 
SOCIO- ECONOMIC STATUS 1 : LOWER 
2 : UPPER LOWER 
3 : MIDDILE 
4 : UPPER MIDDLE 
5 : UPPER 
DOMICILE 1 : RURAL 
2 : URBAN 
TYPE OF FAMILY 1 : NUCLEAR FAMILY 
2 : JOIN FAMILY 
SUBSTANCE USE 1 : ALCOHOL 
2: TOBACCO(CHEWABLE/SMOKING) 
3: BOTH 
120 
 
TYPE OF CANCER 1 : BENIGN 
2: MALIGNANT  
 
STAGE OF CANCER 1 : EARLY BREAST CARCINOMA 
2 : ADVANCED BREAST CARCINOMA 
TYPE OF TREATMENT 1: SURGERY 
2: CHEMOTHERAPY 
3: RADIOTHERAPY 
DURATION OF TREATMENT  1: < 3 WEEKS 
2 : => 3WEEKS 
NO. OF 
CHEMOTHERAPY/RADIOTHERAPY 
0: NIL 
1: < 3 NOS 
2: > 3 NOS 
DURATION OF LAST CT/RT AND LAST 
SURGERY 
1: < 7 WEEKS 
2: > 7 WEEKS  
PAST H/O MENTAL ILLNESS 1 : ABSENT 
2 : PRESENT 
FAMILY H/O MENTAL ILLNESS 1 : ABSENT 
2 : PRESENT 
MEDICAL CO MORBIDITY 0: ABSENT 
1: PRESENT 
HAM – D 1 : NORMAL(<7) 
2 : MILD(8-13) 
3 : MODERATE(14-18) 
4 : SEVERE(19-22) 
5 : VERY SEVERE(>23) 
HAM – A 1: MILD (< 17 SCORE) 
2: MILD – MODERATE ( 18- 24) 
3: MODERATE – SEVERE ( 25 – 30) 
4: SEVERE (>30) 
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